CA2173446C - Ultrasound catheter system having modulated output with feedback control - Google Patents
Ultrasound catheter system having modulated output with feedback control Download PDFInfo
- Publication number
- CA2173446C CA2173446C CA002173446A CA2173446A CA2173446C CA 2173446 C CA2173446 C CA 2173446C CA 002173446 A CA002173446 A CA 002173446A CA 2173446 A CA2173446 A CA 2173446A CA 2173446 C CA2173446 C CA 2173446C
- Authority
- CA
- Canada
- Prior art keywords
- ultrasound
- transmission member
- drive signal
- signal
- transducer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00115—Electrical control of surgical instruments with audible or visual output
- A61B2017/00119—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00141—Details of operation mode continuous, e.g. wave
- A61B2017/00146—Details of operation mode continuous, e.g. wave with multiple frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/0084—Material properties low friction
- A61B2017/00849—Material properties low friction with respect to tissue, e.g. hollow organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00973—Surgical instruments, devices or methods, e.g. tourniquets pedal-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
- A61B2017/22039—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire eccentric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
- A61B2017/22041—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire outside the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/007—Auxiliary appliance with irrigation system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
- A61F2210/0042—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply using a fluid, e.g. circulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0183—Rapid exchange or monorail catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0279—Cannula; Nozzles; Tips; their connection means
Abstract
A method and apparatus for driving an ultrasound transducer (14) coupled to an ultrasound disposed within an elongate catheter (10) has a modulated output and utilizes feedback control. A modulating signal varying in amplitude and continuous in duration modulates an ultrasound transducer drive signal. The resulting modulated ultrasound drive signal is likewise continuous in duration such that it lacks the abrupt accelerations which cause stress to be applied to the ultrasound transmission member in prior art devices. The current of the modulated drive signal is monitored and the voltage thereof is varied in response to changes in the current in order to provide feedback control. A transmission member breakage alarm provides an indication of transmission member breakage in the event that any comparison of the drive energy to the feedback control signal indicates that the desired ultrasonic vibration has been reached at a drive energy level less than the minimum drive energy level typically desired for such desired ultrasound vibration when the ultrasound transmission member is intact.
Description
ULTRASOUND CATHETER SYSTEM RAVING MODULATED OUTPUT
WITH FEEDBACK CONTROL
Field of the Invention The present invention pertains generally to medical devices and more particularly to a method and device for generating ultrasonic energy and delivering said ultrasonic energy to a treatment location within a mammalian body.
Baakaround of the Invention A number of ultrasonic devices have heretofore been proposed for use in ablating or removing obstructive material from blood vessels. Examples of devices which to purportedly utilize ultrasonic energy, alone or in conjunction with other treatment modalities, to remove obstructions from blood vessels include those described in United States Patent Nos. 3,433,226 (Boyd), 3,823,717 (Pohlman, et al.), 4,808,153 (Parisi), 4,936,281 (Stasz), 3,565,062 (Kuris), 4,924,863 (Sterzer), 4,870,953 (Don Michael, et al.), 4,920,954 (Alliger, et al.), and 5,100,423 (Fearnot) as well as other patent publications W087-05739 (Cooper), W089-06515 (Bernstein, et al.), W090-0130 (Sonic Needle Corp.), EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2,438,648 (Pohlman).
Ultrasound transmitting catheters have been utilized to successfully ablate various types of obstructions from blood vessels of humans and animals. Particular success has been observed in ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries. Successful applications of ultrasonic energy to smaller blood vessels, such as the coronary arteries, necessitates the use of ultrasound transmitting catheters which are sufficiently small and flexible to permit transluminal advancement of such sup sir ~~u~ zs~
catheter through the tortuous vasculature of the aortic arch and coronary tree.
Additionally, ultrasound transmitting catheters may be utilized to deliver ultrasonic energy to blood vessel walls for purposes of preventing or reversing vasospasm as described in United States Patent No. 5,324,255 entitled ANGIOPLASTY AND
ABLATIVE DEVICES HAVING ONBOARD ULTRASOUND COMPONENTS AND
DEVICES AND METHODS FOR UTILIZING ULTRASOUND TO TREAT OR
PREVENT VASOSPASM.
In utilizing ultrasound catheters which are of a significant length i.e., longer than approximately 50 cm, additional problems arise. The dissipation of heat generated by the ultrasound transmission member within a catheter is one particular concern. Although it is known to flush coolant, i.e., saline, through the catheter to aid in the dissipation of heat, such procedure is not always adequate.
Bends formed in the ultrasound catheter as it passes through various anatomical vessels of the human body exacerbate the problem of heat dissipation. Such bends provide points of frictional contact between the catheter and the ultrasound transmission member, thus resulting in excessive heat build-up.
As those skilled in the art will appreciate, the build-up of heat within the ultrasound catheter can result in damage to the catheter as well as ineffective operation thereof.
One solution for mitigating the effects of heat buildup within such ultrasound catheters in the prior art has been to pulse the ultrasonic transducer such that ultrasound is applied to the ultrasound transmission member only intermittently. Such devices typically utilize a duty cycle of approximately 30-50%. Thus, heat build-up ceases during the 70-50% off portion of the duty cycle when no ultrasound is being applied to the ultrasound transmission WO 95/09572 ~ PCT/US94/11060 member, thus providing for cooling of the ultrasound catheter.
Those skilled in the art will appreciate that a one hundred per cent duty cycle is defined by an output signal which is not modulated. In applications where heat dissipation is not a problem, such a one hundred per cent duty cycle may be utilized.
However, the use of such pulsing techniques increases the probability of ultrasonic transmission member breakage to due to the large acceleration gradients experienced during the abrupt on/off cycling of the ultrasound transducer.
Such large acceleration gradients result in ultrasound operational frequencies in excess of 20KHz being applied to the ultrasound transmission member. It is preferred that operation ultrasound frequencies be maintained at less than approximately 20KHz so as to limit the large acceleration gradients associated with higher operational ultrasound frequencies.
Those skilled in the art will recognize that such large acceleration gradients are commonly associated with on/off cycling of oscillating mechanical systems and are due to the extremely short time duration over which the system changes from the rest state to the moving state and vice versa.
Additionally, such pulsed systems typically provide reduced ablation efficacy due to the lengthy, i.e., 70-50~, off portion of the duty cycle.
As such, it would be beneficial to provide an ultrasound catheter which is not subject to the problems of inadequate heat dissipation and ultrasound transmission member breakage due to on/off cycling.
Furthermore, contemporary ultrasound catheters are subject to providing ineffective ablation due to variations in the intensity of the ultrasound energy provided at the distal tip of the ultrasound transmission member. Such variations in the intensity of the ultrasound energy at the WO 95/09572 ' PCTIUS94/11060 .~ distal tip of the ultrasound transmission member reduce the efficacy of the ablation process by causing the ultrasound ~i catheter to operate at a lower than desired level. That is, such variations in intensity cause the distal tip of the ultrasound transmission member to radiate less than the desired intensity of ultrasound energy, even though the ultrasound transmission member may be driven at or near its maximum safe level.
Such variations in the intensity of the ultrasound energy radiated at the distal end of the ultrasound transmission member are typically due to bends encountered in the tortuous vessels of the human anatomy, particularly when accessing small vessels such as the coronary artery from remote locations such as the femoral artery. During such procedures the ultrasound catheter is required to make several sharp bends. Such bends inherently result in a reduction in the intensity of the ultrasound energy transmitted through the ultrasound transmission member.
This is thought to be due to radiation and reflection losses inherent in transmitting ultrasound energy through such a bent transmission member and also due to frictional engagement of the ultrasound transmission member with the catheter at the site of the bend.
As such, it would be beneficial to provide an ultrasound catheter which substantially overcomes the problem of inadequate ablation efficacy due to ineffective ultrasound energy transmission, i.e., loose mechanical connection and/or bends in the catheter's path.
Summary of the Invention In accordance with the present invention there is provided a method and apparatus for delivering ultrasonic energy through an elongate catheter to a location within a mammalian body which provides a modulated output to reduce heat build-up, but which modulated output does not ' contribute to premature failure of the ultrasound transmission member due to large acceleration gradients, ' s~rm~rES~'t~~s3 but rather modulated by slow varying functions, including but not limited to sine functions, triangular functions, etc., and also which utilizes feedback control to mitigate the problem of inadequate ablation efficacy due to ineffective ultrasound transmission from the ultrasound transducer to the ablation site.
The method for providing the modulated ultrasound output comprises providing a modulating. signal which varies in amplitude and is continuous in duration.
The phrase "continuous in duration" as used herein is defined to mean not constantly cycling on and off as in the prior art pulsed ultrasound systems whose on-off cycling results in abrupt, extremely large or fast varying functions, but rather providing a constantly present (though varying) signal until the application of ultrasound is discontinued. The modulating signal is applied to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal. The resulting modulated ultrasound transducer drive signal 1 S is continuous in duration and, thus, substantially lacks the abrupt acceleration gradients which are known to cause stress to be applied to the ultrasound transmission member. Thus, the stress commonly associated with premature failure or breakage of the ultrasound transmission member is substantially mitigated by utilizing an ultrasound transducer drive signal which varies in amplitude and which is continuous in duration.
As in the prior art, modulation of the drive signal with an amplitude varying modulating signal reduces the quantity of heat generated by the ultrasound transmission member within the catheter by providing periods of low energy transmission during which the ultrasonic catheter is allowed to cool off. However, modulation of the drive signal with a continuous modulating signal in the present invention mitigates the probability of breaking the ultrasound transmission member due to high acceleration gradients, since such acceleration gradients, which are common in the prior art, do not occur in such continuous waveforms. The modulating signal may comprise a sine wave.
Although the figures show the modulation signal as a signwave, such signal may alternatively comprise many other show, varying functions, other than sine waves.
The modulating signal is preferably an optimized function for a particular application. The modulating signal is preferably selectable from a plurality of different modulating signals, each of the different modulating signals being an optimized function for a particular application. Thus, the modulating signal is preferably optimized for at least one particular application such as the ablation of atherosclerotic plaque or the ablation of thrombotic matter.
Transducer feedback control is provided so as to optimize ablation efficiency by maintaining a defined level of ultrasound energy output at the tip of the ultrasonic catheter.
The use of transducer feedback control thus results in more consistent plaque ablation performance, reduced stress on the catheter, and increase catheter and transducer life.
More consistent placque ablation performance is achieved since the ultrasound energy output at the tip of the ultrasound catheter is maintained at the desired level, rather than being reduced to a level which results in suboptimal performance due to sharpbends in the catheter and loose mechanical connections of the ultrasound transmission member.
Stress on the catheter is reduced since feedback control makes it possible to maintain a desired level of energy output at the tip of the ultrasonic catheter without requiring that the catheter be over driven in order to assure the delivery of adequate ultrasound energy at the tip thereof. Thus, the ultrasound catheter may typically be operated at a lower average level of ultrasound energy than would otherwise be feasible. Reducing the average level of the ultrasound energy transmitted through the ultrasound catheter inherently lowers the stress thereon and consequently increases the life thereof. Additionally, since the ultrasound transducer is driven at a lower level, its life is likewise increased.
Monitoring circuitry senses changes in the ultrasound transducer current level and adjusts the source voltage power supply so as to maintain the transducer current within a specified range. The ultrasound transducer current level is representative of the power delivered to the distal tip of the ultrasound transmission member.
Thus, monitoring the level of the ultrasound transducer current provides a means for monitoring the power delivered at the distal tip of the ultrasound transmission member.
Thus, when the monitoring circuitry detects a higher than specified transducer current, the monitoring circuitry reduces the output of the source voltage power supply so as to bring the current back down into the specified range.
In the preferred embodiment of the present invention, when the monitoring circuitry detects transducer current approaching a higher than specified current level and is thus close to limiting the output of the source voltage power supply, a status indicator, e.g., LED, changes state, preferably from blinking to solid green, so as to indicate that limiting of the source voltage power supply output is about to occur. And, thus, the system is delivering a signal which is resulting in the ultrasound output at the catheter tip.
Sensing of the transducer current is preferably accomplished via a sensing transformer intermediate the source voltage power supply and the piezo-ceramic elements of the ultrasound transducer. In the preferred embodiment of the present invention, the secondary of this sensing transformer supplies a signal to a peak detector through a half-wave rectifier and low pass filter. The resulting ~ll~ST(TIiFE S~EE'~ (~ItE.E 2 WO 95/09572 ~ ~ ~ PCT/US94/11060 -g-signal is fed to an error amplifier having a gain setting of approximately ten. The error amplifier is in communication with the pulse width modular, window comparators, level shifters and push-pull MOSFET stage.
This train of circuitry adjusts the DC voltage supply downward until the error amplifier signal is minimized.
Thus, the output of the ultrasound transducer is maintained within an established range, i.e., above a level of minimum efficacy and below an upper threshold beyond which operation is limited by protocol.
The front panel indicator of the transducer feedback control is connected to a comparator which is AND
functioned with a square wave signal having a frequency of approximately 6Hz. The comparator changes state when the system is within a pre-determined margin of controlling the DC source voltage. This margin is changeable depending upon the type of catheter being driven.
An apparatus for practicing the method of the present invention comprises a modulated ultrasound transducer drive signal generator for providing a modulated ultrasound transducer drive signal; feedback circuitry for sensing the level of the ultrasound drive signal and for increasing the voltage thereof in response to a decrease in the current thereof; an ultrasound transducer receiving the modulated ultrasound transducer drive signal and for providing an ultrasound output; and an ultrasound transmission member attached to the ultrasound transducer for transmitting ultrasound from the ultrasound transducer to an intracorporeal location where required for therapy.
As those skilled in the art will recognize, the catheter is generally comprised of a catheter sheath having a lumen formed therein and having an ultrasound transmission member extending longitudinally through the lumen thereof.
A method for detecting and indicating breakage of the ultrasound transmission member comprises the steps of S~11t1~ESH~E~(RIILE28j WO 95/09572 ~ PCTIUS94/11060 _g_ measuring a feedback control signal representing the ultrasonic vibration at the distal-most extent of the ultrasound transmission member; defining the minimal drive energy typically required to obtain a desired induced feedback control signal when the ultrasound transmission member is unbroken; periodically or continually comparing the drive energy being delivered to the induced feedback control signal being received; and providing a breakage alarm in the event that any comparison of the drive signal to the induced feedback control signal indicates that the desired ultrasonic vibration has been reached at a drive energy less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
Thus, by comparing the drive energy to the feedback control signal, it is possible to detect the occurrence of ultrasound transmission member breakage. This is possible because the drive energy required to obtain the desired induced feedback control signal is substantially different when the ultrasound transmission member is broken from the induced feedback control signal provided when the ultrasound transmission member is unbroken. It takes substantially more drive energy to obtain the desired induced feedback control signal when the ultrasound transmission member is unbroken than it does when the ultrasound transmission is broken since the unbroken ultrasound transmission member represents a greater load and thus requires more energy to drive.
The modulated ultrasound transducer drive signal generator comprises a modulating signal generator for providing a varying and continuous modulating signal; an ultrasound transducer drive signal generator for providing an ultrasound drive signal; and a modulator for applying the modulating signal to the drive signal so as to generate a modulated ultrasound transducer drive signal. A display is preferably provided for displaying information regarding SUBST~'IAE SHEET (~I1,E Z6) the modulated ultrasound transducer drive signal. For example, such information may comprise peak ultrasound power, modulation functions (Dp/dt) power delivery duration, etc.
Thus, the method of the present invention may be used, for example, in treating intravascular blockage by positioning the distal end of the ultrasound transmission member within a lumen of a blood vessel and abutting the distal end of the ultrasound transmission member to the intravascular blockage. Modulation of the output of the ultrasound transducer mitigates heat build-up without subjecting the ultrasound transmission member to premature failure due to the effects of large acceleration gradients and feedback control mitigates the problem of inadequate ablation efficacy due to ineffective ultrasound energy transmission from ultrasound transducer to the ablation site.
Those skilled in the art will recognize the various other intracorporeal applications of the present invention likewise exist.
Therefore, various aspects of the invention are provided as follows:
A method for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, said method characterized by the steps of: providing a modulating signal that is substantially continuously varying in amplitude and is continuous in duration; and applying the modulating signal to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal, wherein the resulting modulated ultrasound transducer drive signal is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency.
An apparatus for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, the apparatus characterized by: a drive signal generator connected to the ultrasound transducer, the drive signal generator being responsive to a modulating signal to provide the transducer with a modulated ultrasound transducer drive signal that is substantially continuously varying in amplitude and is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency;
and the ultrasound transducer receiving -l0a-the modulated ultrasound transducer drive signal and being responsive thereto to provide an ultrasound output; whereby the ultrasound transmission member coupled to the transducer is responsive to the ultrasound output to provide ultrasound energy at its distal end.
These, as well as other advantages of the present invention will be more apparent from the following description and drawings. It is understood that changes in these specific structures shown and described may be made within the scope of the claims without departing from the spirit of the invention.
Brief Description of the Drawings Figure 1 is a perspective view of the ultrasound catheter system according to the present invention;
Figure 2 is a graphic representation of the transducer drive signal and modulating signal according to the prior art;
Figure 3 is a graphic representation of one embodiment of the present invention which utilizes a sine wave function;
Figure 4 is a graphic representation of the transducer drive signal and modulating signal according to the present t~ WO 95/09572 ~' ~ PCT/US94111060 -11- ~ ..~
invention wherein the amplitude of the modulating Signal is increased, thus resulting in a corresponding increase in both the peaks and valleys of the modulated signal;
Figure 5 is a graphic representation of the transducer drive signal and modulating signal according to the present invention wherein the amplitude of the modulating signal is increased, thus resulting in a corresponding increase in only the peaks of the modulated signal;
Figure 6 is an enlarged front view of the control panel of the signal generation and control electronics of the ultrasound catheter of Figure 1;
Figure 7 is a block diagram of the signal generation and control electronics of the present invention illustrating those components utilized for feedback control and waveform modulation; and Figure 8 is a functional block diagram illustrating the procedure utilized in the performance of ablation according to the present invention.
Detailed Description of the Preferred Embodiment The detailed description set forth below in connection with the appended drawings is intended as a description of the presently preferred embodiment of the invention, and is not intended to represent the only form in which the present invention may be constructed or utilized. The description sets forth the functions and sequences of steps for constructing and operating the invention in connection with the illustrated embodiment. It is to be understood, however, that the same or equivalent functions and sequences may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention.
The method and apparatus for removing obstructions from anatomic structures of the present invention is illustrated in Figures 1 and 3-8 which depict a presently preferred embodiment of the invention. Figure 2 depicts ~tlBSlTf IfTE SHEE3 (R1D1 c 26 WO 95!09572 ~, ~~ PCTIUS94/11060 the wave forms of the transducer drive signal and modulating signal according to the prior art.
Referring now to Figure 1, an over-the-wire ultrasound catheter l0 having a proximal end connector assembly 12 mounted on the proximal end thereof is depicted. An ultrasound transducer 14 is connected to the proximal end of the proximal connector assembly 12. Ultrasound generator and control electronics 16 has a foot-actuated on/off switch 18 and is operatively connected to the l0 ultrasound transducer 14 so as to send ultrasound energy through the ultrasound catheter 10, when desired.
An ultrasound transmission member 11 extends through the ultrasound catheter 10 such that the distal end thereof extends from the ultrasound catheter 10 so as to facilitate ablation of plaque, thrombosis, etc., and such that the proximal end thereof attaches to the ultrasound transducer 14.
First 20 and second 22 Y-connections facilitate the introduction of a saline solution for cooling the ultrasound catheter as well as the introduction of radiopaque dyes, anti-spasmodic medication, etc., as desired.
Contemporary ultrasound therapeutic medical devices typically deliver ultrasonic vibration at a frequency of 20-khz and provide either a continuous output at a constant amplitude or a pulsed output between an on state and off state, thus defining a duty cycle typically between 30-50~.
However, attempts to utilize such devices, particularly in percutaneous angioplasty or endovascular ablative procedures wherein the ultrasound delivery member is of signif icant length i . a . , in excess of 50 cm and is exposed to bends, i.e., such as those associated with the tortuous vasculature of the aortic arch and coronary tree have encountered substantial problems. The use of ultrasound devices having a continuous output, i.e., a constant amplitude, for angioplasty procedures may exceed s~~e~ZS~
t WO 95/09572 PCT/US94/11060 the heat dissipating ability of the ultrasound catheter, thus resulting in excessive heat build-up and consequent damage thereto.
Pulsed systems providing an output with alternating on and off periods of ultrasound energy delivery have been developed in an attempt to overcome the disadvantages associated with such thermal build-up in continuous mode ultrasonic catheters. However, such pulsed systems typically result in reduced ablation efficacy and, 1o additionally, often result in premature breakage of the ultrasonic transmission member due to the large acceleration gradients created by the abrupt on/off cycling. Lower ablation efficiency results due to the decreased, i.e., 30-50~, duty cycle of such pulsed systems.
More particularly, reduced ablation efficacy results from the complete lack of ultrasonic energy provided during the off periods, during which no drive signal is applied to the ultrasound transducer. Thus, when utilizing a 50~ duty cycle, for example, only one-half of the energy which would 2o be provided with a 100 duty cycle is delivered to the distal end of the ultrasound transmission member.
The abrupt on/off cycling of such pulse systems results in increased acceleration gradients which stress the ultrasound transmission member, particularly at locations proximate the ultrasonic transducer. Thus, contemporary pulsed systems commonly experience breakage of the ultrasound transmission member at this location.
Referring now to Figure 2, prior art pulsed ultrasonic catheters utilize a square wave modulating signal 30 which is used to modulate a continuous transducer drive signal so as to produce a transducer drive signal 32 which is, thus, pulsed in a complimentary manner. The pulsed transducer drive signal defines an output having full amplitude at times corresponding to the peaks of the square wave modulating signal and having zero output at times ~,s~~e (~u~ zs WO 95/09572 ~ PCT/US94/11060 corresponding to the valleys of the square wave modulating signal.
As will be appreciated by those skilled in the art, the transition of the pulsed or modulated transducer drive signal from the off or no output state to the on state causes a very high acceleration gradient as the ultrasound transmission member moves from a rest position to movement and vice versa. Thus, the beginnings 31 and endings 33 of each pulse of the transducer drive signal result in high levels of stress being applied to the ultrasound transmission member.
Such high acceleration gradients subject the ultrasound transmission member 11 to forces which are frequently sufficient to result in damage thereto, i.e., breaking away of the distal portion of the ultrasound transmission member 11.
Referring now to Figure 3, the modulating signal 40 of the present invention is a varying and continuous waveform, preferably a sine wave, which is used to modulate a continuous constant amplitude transducer drive signal so as to produce a modulated transducer drive signal 42 which is thus continuous and varying in amplitude. An effective duty cycle is achieved without actually allowing the ultrasound transmission member to come to a state of rest.
Modulation of the transducer drive signal according to the present invention eliminates the need to induce the high acceleration gradients associated with bringing the ultrasound transmission member from a state of rest to one of motion and vice versa. Thus, those skilled in the art will appreciate that the stresses to which the ultrasound transmission member are exposed are substantially reduced.
As shown in Figures 4 and 5, the modulation of the wave form brings about changes in the resultant effective duty cycle. For example, as the amplitude of the modulated ' signal is increased, the effective duty cycle is shortened.
The effective duty cycle can thus be varied, as desired, by rur~ sir ~~u~ zs~
varying the amplitude of the modulating signal and the method of modulation.
Referring now to Figures 4 and 5, the effective duty cycle can be varied as a result of changes in the amplitude of the modulating signal.
Thus, increasing the amplitude of the modulating signal 40 of Figure 3 may result in either increasing both the peaks 54 and valleys 56 of the transducer drive signal 52 as illustrated in Figure 4 or and increasing only the peaks 64 (and not the valleys 66) of the transducer drive signal 62 as illustrated in Figure 5.
Referring now to Figure 6, the controls and indicators of the signal generator and control electronics 16 are better illustrated. The front panel comprises a shut-down alarm indicator 70 which provides a visual indication that the ultrasound signal generator is not providing an output.
Optionally, an audible enunciator may additionally be utilized to indicate shut-down of the system. A transducer connector 72 facilitates interconnection of the ultrasound signal generator and control electronics 16 and the ultrasound transducer 14 via interconnecting cable 15 (as shown in Figure 1). A front panel jack 74 facilitates connection of the ultrasound signal generator and control electronics 16 with a foot switch 18 via cable 17 (as shown in Figure 1), so as to facilitate remote operation of the ultrasound signal generator and control electronics 16.
Thus, the foot switch 18 may be utilized to control the application of ultrasound energy through the ultrasound transmission member 11 to the plaque or thrombosis, as desired.
Digital readout 76 indicates the remaining catheter lifetime. For example, contemporary protocol requires that ultrasound catheters be replaced after five(5) minutes of total use. Thus, by viewing digital readout 76, the user may readily ascertain the time remaining in the useful life of the ultrasound catheter.
SiiS~E~ (aU~ Z6~
WO 95/09572 ~ PCTIUS94/11060 For example, status indicator 78 may illuminate to indicate an operational condition of the ultrasound catheter. That is, status indicator 78 illuminates when ultrasound energy is being transmitted through the ultrasound transmission member 11.
As a further example, status indicator 80 may illuminate during the intermittent off-period of the ultrasound catheter 10. Contemporary protocol requires a five second off-period after each thirty seconds of to ultrasonic energy applied.
As a still further example, status indicator 82 may illuminate to indicate that the catheter life has expired, i.e., five minutes of total time has accumulated during which ultrasound energy has been applied through the ultrasound transmission member 11.
Down 84 and up 86 membrane switches facilitate cycling between three different modes of operation. The selected mode of operation is indicated by digital indicator 88.
Each time either the down 84 or the up 86 membrane switch is pushed, the selected mode of operation changes.
The irrigation mode is indicated by an "I" displayed in digital indicator 88. Cooling fluid, typically saline, is provided through ultrasound catheter 10 and no ultrasonic energy is applied when the irrigation mode is selected.
The peripheral mode is indicated by a "P" displayed in the digital indicator 88. When the peripheral mode of operation is selected, appropriate feedback control is maintained. Feedback control during peripheral mode operation may vary from that which is employed during coronary mode operation. Indeed, various different modes of operation may be selected wherein each different mode of operation corresponds to a different type of feedback control. Differences in feedback control may be provided to accommodate differences in catheter length, tip size, and power density required at the catheter tip.
StIBSTI~Ut'E SHEET (HUIE I6) WO 95!09572 PCT/US94/11060 The cardiac mode is indicated by a "C". Feedback control is provided so as to optimize ablation effectiveness while maintaining the ultrasound output level within protocol limits. The effects of sharp bends occurring in the tortuous path from the femoral artery to the coronary arteries, for example, are mitigated.
It will be recognized by those skilled in the art that the feedback control signal may comprise a variety of different signals generated by a variety of different means. For example, the feedback control signal may comprise the ultrasound transducer current level.
Alternatively, the feedback control signal may comprise a signal generated by a vibration transducer mounted at the distal tip of the ultrasound catheter so as to directly measure ultrasonic vibration thereof.
Referring now to Figure 7, a block diagram of the signal generation and control electronics 16 is provided.
A foot switch 100 controls the generation of an unmodulated transducer drive signal via the source voltage supply 102.
The unmodulated transducer drive signal is provided by the source voltage supply 102 to a modulator 104. A modulating signal, preferably a sine wave, is provided by the modulating signal source 106 to the modulator 104 where modulation of the transducer drive signal is effected thereby. The modulator 104 provides a modulated transducer drive signal to the ultrasound transducer 108.
The current provided to the ultrasound transducer 108 is monitored by the current monitor 110, the output of which is used by the feedback control 112 to effect variations in the output of the source voltage supply 102, as required. Status indicator 113 (corresponding to status indicator 78 of Figure 6) provides an indication of when feedback control is being utilized to effect changes in the output of the source voltage supply 102.
Sensing of the transducer current is preferably accomplished via a sensing transformer intermediate the SStII~STtilIT~ ~i'EE~' (RillE 26~
source voltage power supply and the piezo-ceramic elements of the ultrasound transducer. In the preferred embodiment of the present invention, the secondary of this sensing transformer supplies a signal to a peak detector through a half-wave rectifier and low pass filter. The resulting signal is fed to an error amplifier having a gain setting of approximately ten. The error amplifier is in communication with the pulse width modular, window comparators, level shifters and push-pull MOSFET stage.
This train of circuitry adjusts the DC voltage supply downward until the error amplifier signal is minimized.
Thus, the output of the ultrasound transducer is maintained within an established range, i.e., above a level of minimum efficacy and below an upper threshold beyond which operation is limited by protocol.
The front panel indicator of the transducer feedback control is connected to a comparator which is AND
functioned with a square wave signal having a frequency of approximately 6Hz. The comparator changes state when the system is within a pre-determined margin of controlling the DC source voltage. This margin is changeable depending upon the type of catheter being driven.
The irrigate only/cardiac/peripheral selector 114 is utilized to select the desired mode of operation, i.e., irrigate only, cardiac, or peripheral.
Thirty-second timer/five-second timer 116 applies the output of the modulator 104 to the ultrasound transducer 108 according to contemporary protocol such that each thirty seconds of ultrasound energy applied through the ultrasound catheter 10 is followed by five seconds of off time. Rest/active indicator 118 (corresponding to status indicator 80 of Figure 6) provides an indication of whether the ultrasound catheter is in the thirty-second on time or the five-second off period.
The five accumulated minutes timer 120 discontinues the application of ultrasound energy after five(5) minutes ' SUBSTITUTE SHEET (RULE 2G) WO 95/09572 ~ PCT/US94/11060 of total time have accumulated for a particular ultrasound catheter 10. The timer must be manually reset so as to confirm that the ultrasound catheter 10 has been replaced.
Catheter indicator 122 (corresponding to status indicator 82 of Figure 6) provides a quick visual indication of the status of the catheter, i.e., whether or not five(5) accumulated minutes have elapsed. The catheter accumulated time display 124 (corresponding to distal readout 76 of Figure 6) provides a visual indication of the time remaining for operation of the ultrasound catheter 10.
The ultrasound transmission member breakage detector 109 provides a breakage alarm, either via status indicator 112 or via a separate dedicated alarm, in the event that any comparison of the drive energy to the induced feedback control signal indicates that the desired ultrasonic vibration has been reached at a drive energy level less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
Now referring to Figure 8, operation of the ultrasound catheter having modulated output with feedback control of the present invention is illustrated. The user first selects the irrigation mode 200, then depresses the foot pedal to initiate irrigation 202, as desired. Next, either the cardiac or peripheral mode of operation 204 is selected.
If the cardiac mode of operation is selected, the ablation procedure 207 is performed with feedback control.
If the peripheral mode of operation is selected, then the ablation procedure is performed 206 with a different amount of total power delivered to the catheter and with different feedback control, if desired. A solid status light 78 (Figure 6) indicates effective driving of the transmission member by the transducer and a blinking status light 78 indicates ineffective driving of the transmission member.
~us~~ (sup 2~~
WO 95!09572 PCT/US94/11060 In either the peripheral or cardiac mode of operation, the output of the source voltage supply is modulated so as to facilitate adequate cooling of the ultrasound catheter while minimizing stresses placed thereupon due to abrupt 5 accelerations as occurs in the prior art.
If the status light 78 blinks 208 then the ultrasound transmission member may be checked for proper connection 210 and/or potentially manipulated so as to provide for the better transmission of ultrasound energy, i.e., by 10 manipulating the ultrasound catheter so as to loosen any bends therein, where possible. As long as the status light does not blink 208, then the procedure proceeds according to protocol wherein thirty-seconds of operation are followed by five-seconds of off-time 212. If the status light continues to blink, such blinking may be an indication of a break or fracture of the transmission member and appropriate measures may be undertaken to replace the catheter before continuing.
Alternatively, a separate indicator may be provided to specifically indicate breakage of the ultrasound transmission member. Such breakage would be detected by sensing the presence of a desired feedback current when less than the normally required drive signal is provided.
The procedure may continue until the catheter life expired indicator 82 (Figure 6) indicates that five minutes of total time have accumulated 214 on the catheter in use.
The old catheter must be removed and a new catheter utilized prior to proceeding.
Thus, thermal build-up within the ultrasound catheter is controlled by optimizing the duty cycle of the transducer drive signal such that maximum ablation is achieved with acceptable thermal build-up.
Additionally, the wave form of the transducer drive signal can be optimized so as to provide effective ablation upon a wide range of body tissue, plaque, clots, thrombus, etc. ' s~'~ (au~ Zs) ~I'~344~
WO 95/09572 ~ , , PCT/US94/11060 p..
For example, a variety of different pre-programmed combinations of modulated signal function and source voltage amplitude may optionally be provided so as to optimize the application of ultrasound energy for a selected therapeutic function.
Breakage of the ultrasound transmission member may be optionally be detected. Differences in the feedback signal provided when the ultrasound catheter binds, i.e., due to excessive bending, and when the ultrasound transmission member fractures or is broken facilitate electronic differentiation between these two conditions. When the ultrasound transmission member binds, the feedback current decreases and in response to this decrease in the fee aback current signal, the source voltage is increased. However, in the instance of ultrasound transmission member breakage, a normal feedback current signal is generated with the application of a substantially reduced source voltage. The normal feedback current signal results since it is possible to drive the shorter length of the broken ultrasound transmission member with less than the normally required source voltage. Detection of this condition makes it possible to indicate breakage of the ultrasound transmission member to the user so that the procedure may be halted and a new catheter provided.
Those skilled in the art will recognize that breakage of the ultrasound transmission member typically occurs within a few ultrasound modes of the ultrasound transducer, where ultrasound energy density concentration is the greatest. Thus, the difference in the source voltage required to drive a normal, i.e., unbroken, ultrasound transmission member and that required to drive a much shorter broken ultrasound transmission member is substantial.
It is understood that the exemplary method and apparatus for removing obstructions from anatomical structures described herein and shown in the drawings su~~ leu~zs~
WO 95/09572 PCT/US94/ilOGO
represents only a presently preferred embodiment of the invention. Indeed, various modifications and additions may be made to such embodiment without departing from the spirit and scope of the invention. For example the means for modulating the transducer drive signal with the modulating signal may comprise a variety type of circuits utilizing various solid state devices, vacuum tubes, and/or microprocessor means. Also, those skilled in the art will recognize that various thresholds for effecting changes in the output of the source voltage supply 102 in response to the input to the ultrasound transducer 108 are suitable, depending upon the physical characteristics of the ultrasound catheter, and the ultrasound energy requirements of the particular procedure being performed. Thus, these and other modifications and additions may be obvious to those skilled in the art and may be implemented to adapt the present invention for use in a variety of different applications.
suesntutE s~ (au~ zs)
WITH FEEDBACK CONTROL
Field of the Invention The present invention pertains generally to medical devices and more particularly to a method and device for generating ultrasonic energy and delivering said ultrasonic energy to a treatment location within a mammalian body.
Baakaround of the Invention A number of ultrasonic devices have heretofore been proposed for use in ablating or removing obstructive material from blood vessels. Examples of devices which to purportedly utilize ultrasonic energy, alone or in conjunction with other treatment modalities, to remove obstructions from blood vessels include those described in United States Patent Nos. 3,433,226 (Boyd), 3,823,717 (Pohlman, et al.), 4,808,153 (Parisi), 4,936,281 (Stasz), 3,565,062 (Kuris), 4,924,863 (Sterzer), 4,870,953 (Don Michael, et al.), 4,920,954 (Alliger, et al.), and 5,100,423 (Fearnot) as well as other patent publications W087-05739 (Cooper), W089-06515 (Bernstein, et al.), W090-0130 (Sonic Needle Corp.), EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2,438,648 (Pohlman).
Ultrasound transmitting catheters have been utilized to successfully ablate various types of obstructions from blood vessels of humans and animals. Particular success has been observed in ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries. Successful applications of ultrasonic energy to smaller blood vessels, such as the coronary arteries, necessitates the use of ultrasound transmitting catheters which are sufficiently small and flexible to permit transluminal advancement of such sup sir ~~u~ zs~
catheter through the tortuous vasculature of the aortic arch and coronary tree.
Additionally, ultrasound transmitting catheters may be utilized to deliver ultrasonic energy to blood vessel walls for purposes of preventing or reversing vasospasm as described in United States Patent No. 5,324,255 entitled ANGIOPLASTY AND
ABLATIVE DEVICES HAVING ONBOARD ULTRASOUND COMPONENTS AND
DEVICES AND METHODS FOR UTILIZING ULTRASOUND TO TREAT OR
PREVENT VASOSPASM.
In utilizing ultrasound catheters which are of a significant length i.e., longer than approximately 50 cm, additional problems arise. The dissipation of heat generated by the ultrasound transmission member within a catheter is one particular concern. Although it is known to flush coolant, i.e., saline, through the catheter to aid in the dissipation of heat, such procedure is not always adequate.
Bends formed in the ultrasound catheter as it passes through various anatomical vessels of the human body exacerbate the problem of heat dissipation. Such bends provide points of frictional contact between the catheter and the ultrasound transmission member, thus resulting in excessive heat build-up.
As those skilled in the art will appreciate, the build-up of heat within the ultrasound catheter can result in damage to the catheter as well as ineffective operation thereof.
One solution for mitigating the effects of heat buildup within such ultrasound catheters in the prior art has been to pulse the ultrasonic transducer such that ultrasound is applied to the ultrasound transmission member only intermittently. Such devices typically utilize a duty cycle of approximately 30-50%. Thus, heat build-up ceases during the 70-50% off portion of the duty cycle when no ultrasound is being applied to the ultrasound transmission WO 95/09572 ~ PCT/US94/11060 member, thus providing for cooling of the ultrasound catheter.
Those skilled in the art will appreciate that a one hundred per cent duty cycle is defined by an output signal which is not modulated. In applications where heat dissipation is not a problem, such a one hundred per cent duty cycle may be utilized.
However, the use of such pulsing techniques increases the probability of ultrasonic transmission member breakage to due to the large acceleration gradients experienced during the abrupt on/off cycling of the ultrasound transducer.
Such large acceleration gradients result in ultrasound operational frequencies in excess of 20KHz being applied to the ultrasound transmission member. It is preferred that operation ultrasound frequencies be maintained at less than approximately 20KHz so as to limit the large acceleration gradients associated with higher operational ultrasound frequencies.
Those skilled in the art will recognize that such large acceleration gradients are commonly associated with on/off cycling of oscillating mechanical systems and are due to the extremely short time duration over which the system changes from the rest state to the moving state and vice versa.
Additionally, such pulsed systems typically provide reduced ablation efficacy due to the lengthy, i.e., 70-50~, off portion of the duty cycle.
As such, it would be beneficial to provide an ultrasound catheter which is not subject to the problems of inadequate heat dissipation and ultrasound transmission member breakage due to on/off cycling.
Furthermore, contemporary ultrasound catheters are subject to providing ineffective ablation due to variations in the intensity of the ultrasound energy provided at the distal tip of the ultrasound transmission member. Such variations in the intensity of the ultrasound energy at the WO 95/09572 ' PCTIUS94/11060 .~ distal tip of the ultrasound transmission member reduce the efficacy of the ablation process by causing the ultrasound ~i catheter to operate at a lower than desired level. That is, such variations in intensity cause the distal tip of the ultrasound transmission member to radiate less than the desired intensity of ultrasound energy, even though the ultrasound transmission member may be driven at or near its maximum safe level.
Such variations in the intensity of the ultrasound energy radiated at the distal end of the ultrasound transmission member are typically due to bends encountered in the tortuous vessels of the human anatomy, particularly when accessing small vessels such as the coronary artery from remote locations such as the femoral artery. During such procedures the ultrasound catheter is required to make several sharp bends. Such bends inherently result in a reduction in the intensity of the ultrasound energy transmitted through the ultrasound transmission member.
This is thought to be due to radiation and reflection losses inherent in transmitting ultrasound energy through such a bent transmission member and also due to frictional engagement of the ultrasound transmission member with the catheter at the site of the bend.
As such, it would be beneficial to provide an ultrasound catheter which substantially overcomes the problem of inadequate ablation efficacy due to ineffective ultrasound energy transmission, i.e., loose mechanical connection and/or bends in the catheter's path.
Summary of the Invention In accordance with the present invention there is provided a method and apparatus for delivering ultrasonic energy through an elongate catheter to a location within a mammalian body which provides a modulated output to reduce heat build-up, but which modulated output does not ' contribute to premature failure of the ultrasound transmission member due to large acceleration gradients, ' s~rm~rES~'t~~s3 but rather modulated by slow varying functions, including but not limited to sine functions, triangular functions, etc., and also which utilizes feedback control to mitigate the problem of inadequate ablation efficacy due to ineffective ultrasound transmission from the ultrasound transducer to the ablation site.
The method for providing the modulated ultrasound output comprises providing a modulating. signal which varies in amplitude and is continuous in duration.
The phrase "continuous in duration" as used herein is defined to mean not constantly cycling on and off as in the prior art pulsed ultrasound systems whose on-off cycling results in abrupt, extremely large or fast varying functions, but rather providing a constantly present (though varying) signal until the application of ultrasound is discontinued. The modulating signal is applied to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal. The resulting modulated ultrasound transducer drive signal 1 S is continuous in duration and, thus, substantially lacks the abrupt acceleration gradients which are known to cause stress to be applied to the ultrasound transmission member. Thus, the stress commonly associated with premature failure or breakage of the ultrasound transmission member is substantially mitigated by utilizing an ultrasound transducer drive signal which varies in amplitude and which is continuous in duration.
As in the prior art, modulation of the drive signal with an amplitude varying modulating signal reduces the quantity of heat generated by the ultrasound transmission member within the catheter by providing periods of low energy transmission during which the ultrasonic catheter is allowed to cool off. However, modulation of the drive signal with a continuous modulating signal in the present invention mitigates the probability of breaking the ultrasound transmission member due to high acceleration gradients, since such acceleration gradients, which are common in the prior art, do not occur in such continuous waveforms. The modulating signal may comprise a sine wave.
Although the figures show the modulation signal as a signwave, such signal may alternatively comprise many other show, varying functions, other than sine waves.
The modulating signal is preferably an optimized function for a particular application. The modulating signal is preferably selectable from a plurality of different modulating signals, each of the different modulating signals being an optimized function for a particular application. Thus, the modulating signal is preferably optimized for at least one particular application such as the ablation of atherosclerotic plaque or the ablation of thrombotic matter.
Transducer feedback control is provided so as to optimize ablation efficiency by maintaining a defined level of ultrasound energy output at the tip of the ultrasonic catheter.
The use of transducer feedback control thus results in more consistent plaque ablation performance, reduced stress on the catheter, and increase catheter and transducer life.
More consistent placque ablation performance is achieved since the ultrasound energy output at the tip of the ultrasound catheter is maintained at the desired level, rather than being reduced to a level which results in suboptimal performance due to sharpbends in the catheter and loose mechanical connections of the ultrasound transmission member.
Stress on the catheter is reduced since feedback control makes it possible to maintain a desired level of energy output at the tip of the ultrasonic catheter without requiring that the catheter be over driven in order to assure the delivery of adequate ultrasound energy at the tip thereof. Thus, the ultrasound catheter may typically be operated at a lower average level of ultrasound energy than would otherwise be feasible. Reducing the average level of the ultrasound energy transmitted through the ultrasound catheter inherently lowers the stress thereon and consequently increases the life thereof. Additionally, since the ultrasound transducer is driven at a lower level, its life is likewise increased.
Monitoring circuitry senses changes in the ultrasound transducer current level and adjusts the source voltage power supply so as to maintain the transducer current within a specified range. The ultrasound transducer current level is representative of the power delivered to the distal tip of the ultrasound transmission member.
Thus, monitoring the level of the ultrasound transducer current provides a means for monitoring the power delivered at the distal tip of the ultrasound transmission member.
Thus, when the monitoring circuitry detects a higher than specified transducer current, the monitoring circuitry reduces the output of the source voltage power supply so as to bring the current back down into the specified range.
In the preferred embodiment of the present invention, when the monitoring circuitry detects transducer current approaching a higher than specified current level and is thus close to limiting the output of the source voltage power supply, a status indicator, e.g., LED, changes state, preferably from blinking to solid green, so as to indicate that limiting of the source voltage power supply output is about to occur. And, thus, the system is delivering a signal which is resulting in the ultrasound output at the catheter tip.
Sensing of the transducer current is preferably accomplished via a sensing transformer intermediate the source voltage power supply and the piezo-ceramic elements of the ultrasound transducer. In the preferred embodiment of the present invention, the secondary of this sensing transformer supplies a signal to a peak detector through a half-wave rectifier and low pass filter. The resulting ~ll~ST(TIiFE S~EE'~ (~ItE.E 2 WO 95/09572 ~ ~ ~ PCT/US94/11060 -g-signal is fed to an error amplifier having a gain setting of approximately ten. The error amplifier is in communication with the pulse width modular, window comparators, level shifters and push-pull MOSFET stage.
This train of circuitry adjusts the DC voltage supply downward until the error amplifier signal is minimized.
Thus, the output of the ultrasound transducer is maintained within an established range, i.e., above a level of minimum efficacy and below an upper threshold beyond which operation is limited by protocol.
The front panel indicator of the transducer feedback control is connected to a comparator which is AND
functioned with a square wave signal having a frequency of approximately 6Hz. The comparator changes state when the system is within a pre-determined margin of controlling the DC source voltage. This margin is changeable depending upon the type of catheter being driven.
An apparatus for practicing the method of the present invention comprises a modulated ultrasound transducer drive signal generator for providing a modulated ultrasound transducer drive signal; feedback circuitry for sensing the level of the ultrasound drive signal and for increasing the voltage thereof in response to a decrease in the current thereof; an ultrasound transducer receiving the modulated ultrasound transducer drive signal and for providing an ultrasound output; and an ultrasound transmission member attached to the ultrasound transducer for transmitting ultrasound from the ultrasound transducer to an intracorporeal location where required for therapy.
As those skilled in the art will recognize, the catheter is generally comprised of a catheter sheath having a lumen formed therein and having an ultrasound transmission member extending longitudinally through the lumen thereof.
A method for detecting and indicating breakage of the ultrasound transmission member comprises the steps of S~11t1~ESH~E~(RIILE28j WO 95/09572 ~ PCTIUS94/11060 _g_ measuring a feedback control signal representing the ultrasonic vibration at the distal-most extent of the ultrasound transmission member; defining the minimal drive energy typically required to obtain a desired induced feedback control signal when the ultrasound transmission member is unbroken; periodically or continually comparing the drive energy being delivered to the induced feedback control signal being received; and providing a breakage alarm in the event that any comparison of the drive signal to the induced feedback control signal indicates that the desired ultrasonic vibration has been reached at a drive energy less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
Thus, by comparing the drive energy to the feedback control signal, it is possible to detect the occurrence of ultrasound transmission member breakage. This is possible because the drive energy required to obtain the desired induced feedback control signal is substantially different when the ultrasound transmission member is broken from the induced feedback control signal provided when the ultrasound transmission member is unbroken. It takes substantially more drive energy to obtain the desired induced feedback control signal when the ultrasound transmission member is unbroken than it does when the ultrasound transmission is broken since the unbroken ultrasound transmission member represents a greater load and thus requires more energy to drive.
The modulated ultrasound transducer drive signal generator comprises a modulating signal generator for providing a varying and continuous modulating signal; an ultrasound transducer drive signal generator for providing an ultrasound drive signal; and a modulator for applying the modulating signal to the drive signal so as to generate a modulated ultrasound transducer drive signal. A display is preferably provided for displaying information regarding SUBST~'IAE SHEET (~I1,E Z6) the modulated ultrasound transducer drive signal. For example, such information may comprise peak ultrasound power, modulation functions (Dp/dt) power delivery duration, etc.
Thus, the method of the present invention may be used, for example, in treating intravascular blockage by positioning the distal end of the ultrasound transmission member within a lumen of a blood vessel and abutting the distal end of the ultrasound transmission member to the intravascular blockage. Modulation of the output of the ultrasound transducer mitigates heat build-up without subjecting the ultrasound transmission member to premature failure due to the effects of large acceleration gradients and feedback control mitigates the problem of inadequate ablation efficacy due to ineffective ultrasound energy transmission from ultrasound transducer to the ablation site.
Those skilled in the art will recognize the various other intracorporeal applications of the present invention likewise exist.
Therefore, various aspects of the invention are provided as follows:
A method for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, said method characterized by the steps of: providing a modulating signal that is substantially continuously varying in amplitude and is continuous in duration; and applying the modulating signal to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal, wherein the resulting modulated ultrasound transducer drive signal is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency.
An apparatus for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, the apparatus characterized by: a drive signal generator connected to the ultrasound transducer, the drive signal generator being responsive to a modulating signal to provide the transducer with a modulated ultrasound transducer drive signal that is substantially continuously varying in amplitude and is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency;
and the ultrasound transducer receiving -l0a-the modulated ultrasound transducer drive signal and being responsive thereto to provide an ultrasound output; whereby the ultrasound transmission member coupled to the transducer is responsive to the ultrasound output to provide ultrasound energy at its distal end.
These, as well as other advantages of the present invention will be more apparent from the following description and drawings. It is understood that changes in these specific structures shown and described may be made within the scope of the claims without departing from the spirit of the invention.
Brief Description of the Drawings Figure 1 is a perspective view of the ultrasound catheter system according to the present invention;
Figure 2 is a graphic representation of the transducer drive signal and modulating signal according to the prior art;
Figure 3 is a graphic representation of one embodiment of the present invention which utilizes a sine wave function;
Figure 4 is a graphic representation of the transducer drive signal and modulating signal according to the present t~ WO 95/09572 ~' ~ PCT/US94111060 -11- ~ ..~
invention wherein the amplitude of the modulating Signal is increased, thus resulting in a corresponding increase in both the peaks and valleys of the modulated signal;
Figure 5 is a graphic representation of the transducer drive signal and modulating signal according to the present invention wherein the amplitude of the modulating signal is increased, thus resulting in a corresponding increase in only the peaks of the modulated signal;
Figure 6 is an enlarged front view of the control panel of the signal generation and control electronics of the ultrasound catheter of Figure 1;
Figure 7 is a block diagram of the signal generation and control electronics of the present invention illustrating those components utilized for feedback control and waveform modulation; and Figure 8 is a functional block diagram illustrating the procedure utilized in the performance of ablation according to the present invention.
Detailed Description of the Preferred Embodiment The detailed description set forth below in connection with the appended drawings is intended as a description of the presently preferred embodiment of the invention, and is not intended to represent the only form in which the present invention may be constructed or utilized. The description sets forth the functions and sequences of steps for constructing and operating the invention in connection with the illustrated embodiment. It is to be understood, however, that the same or equivalent functions and sequences may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention.
The method and apparatus for removing obstructions from anatomic structures of the present invention is illustrated in Figures 1 and 3-8 which depict a presently preferred embodiment of the invention. Figure 2 depicts ~tlBSlTf IfTE SHEE3 (R1D1 c 26 WO 95!09572 ~, ~~ PCTIUS94/11060 the wave forms of the transducer drive signal and modulating signal according to the prior art.
Referring now to Figure 1, an over-the-wire ultrasound catheter l0 having a proximal end connector assembly 12 mounted on the proximal end thereof is depicted. An ultrasound transducer 14 is connected to the proximal end of the proximal connector assembly 12. Ultrasound generator and control electronics 16 has a foot-actuated on/off switch 18 and is operatively connected to the l0 ultrasound transducer 14 so as to send ultrasound energy through the ultrasound catheter 10, when desired.
An ultrasound transmission member 11 extends through the ultrasound catheter 10 such that the distal end thereof extends from the ultrasound catheter 10 so as to facilitate ablation of plaque, thrombosis, etc., and such that the proximal end thereof attaches to the ultrasound transducer 14.
First 20 and second 22 Y-connections facilitate the introduction of a saline solution for cooling the ultrasound catheter as well as the introduction of radiopaque dyes, anti-spasmodic medication, etc., as desired.
Contemporary ultrasound therapeutic medical devices typically deliver ultrasonic vibration at a frequency of 20-khz and provide either a continuous output at a constant amplitude or a pulsed output between an on state and off state, thus defining a duty cycle typically between 30-50~.
However, attempts to utilize such devices, particularly in percutaneous angioplasty or endovascular ablative procedures wherein the ultrasound delivery member is of signif icant length i . a . , in excess of 50 cm and is exposed to bends, i.e., such as those associated with the tortuous vasculature of the aortic arch and coronary tree have encountered substantial problems. The use of ultrasound devices having a continuous output, i.e., a constant amplitude, for angioplasty procedures may exceed s~~e~ZS~
t WO 95/09572 PCT/US94/11060 the heat dissipating ability of the ultrasound catheter, thus resulting in excessive heat build-up and consequent damage thereto.
Pulsed systems providing an output with alternating on and off periods of ultrasound energy delivery have been developed in an attempt to overcome the disadvantages associated with such thermal build-up in continuous mode ultrasonic catheters. However, such pulsed systems typically result in reduced ablation efficacy and, 1o additionally, often result in premature breakage of the ultrasonic transmission member due to the large acceleration gradients created by the abrupt on/off cycling. Lower ablation efficiency results due to the decreased, i.e., 30-50~, duty cycle of such pulsed systems.
More particularly, reduced ablation efficacy results from the complete lack of ultrasonic energy provided during the off periods, during which no drive signal is applied to the ultrasound transducer. Thus, when utilizing a 50~ duty cycle, for example, only one-half of the energy which would 2o be provided with a 100 duty cycle is delivered to the distal end of the ultrasound transmission member.
The abrupt on/off cycling of such pulse systems results in increased acceleration gradients which stress the ultrasound transmission member, particularly at locations proximate the ultrasonic transducer. Thus, contemporary pulsed systems commonly experience breakage of the ultrasound transmission member at this location.
Referring now to Figure 2, prior art pulsed ultrasonic catheters utilize a square wave modulating signal 30 which is used to modulate a continuous transducer drive signal so as to produce a transducer drive signal 32 which is, thus, pulsed in a complimentary manner. The pulsed transducer drive signal defines an output having full amplitude at times corresponding to the peaks of the square wave modulating signal and having zero output at times ~,s~~e (~u~ zs WO 95/09572 ~ PCT/US94/11060 corresponding to the valleys of the square wave modulating signal.
As will be appreciated by those skilled in the art, the transition of the pulsed or modulated transducer drive signal from the off or no output state to the on state causes a very high acceleration gradient as the ultrasound transmission member moves from a rest position to movement and vice versa. Thus, the beginnings 31 and endings 33 of each pulse of the transducer drive signal result in high levels of stress being applied to the ultrasound transmission member.
Such high acceleration gradients subject the ultrasound transmission member 11 to forces which are frequently sufficient to result in damage thereto, i.e., breaking away of the distal portion of the ultrasound transmission member 11.
Referring now to Figure 3, the modulating signal 40 of the present invention is a varying and continuous waveform, preferably a sine wave, which is used to modulate a continuous constant amplitude transducer drive signal so as to produce a modulated transducer drive signal 42 which is thus continuous and varying in amplitude. An effective duty cycle is achieved without actually allowing the ultrasound transmission member to come to a state of rest.
Modulation of the transducer drive signal according to the present invention eliminates the need to induce the high acceleration gradients associated with bringing the ultrasound transmission member from a state of rest to one of motion and vice versa. Thus, those skilled in the art will appreciate that the stresses to which the ultrasound transmission member are exposed are substantially reduced.
As shown in Figures 4 and 5, the modulation of the wave form brings about changes in the resultant effective duty cycle. For example, as the amplitude of the modulated ' signal is increased, the effective duty cycle is shortened.
The effective duty cycle can thus be varied, as desired, by rur~ sir ~~u~ zs~
varying the amplitude of the modulating signal and the method of modulation.
Referring now to Figures 4 and 5, the effective duty cycle can be varied as a result of changes in the amplitude of the modulating signal.
Thus, increasing the amplitude of the modulating signal 40 of Figure 3 may result in either increasing both the peaks 54 and valleys 56 of the transducer drive signal 52 as illustrated in Figure 4 or and increasing only the peaks 64 (and not the valleys 66) of the transducer drive signal 62 as illustrated in Figure 5.
Referring now to Figure 6, the controls and indicators of the signal generator and control electronics 16 are better illustrated. The front panel comprises a shut-down alarm indicator 70 which provides a visual indication that the ultrasound signal generator is not providing an output.
Optionally, an audible enunciator may additionally be utilized to indicate shut-down of the system. A transducer connector 72 facilitates interconnection of the ultrasound signal generator and control electronics 16 and the ultrasound transducer 14 via interconnecting cable 15 (as shown in Figure 1). A front panel jack 74 facilitates connection of the ultrasound signal generator and control electronics 16 with a foot switch 18 via cable 17 (as shown in Figure 1), so as to facilitate remote operation of the ultrasound signal generator and control electronics 16.
Thus, the foot switch 18 may be utilized to control the application of ultrasound energy through the ultrasound transmission member 11 to the plaque or thrombosis, as desired.
Digital readout 76 indicates the remaining catheter lifetime. For example, contemporary protocol requires that ultrasound catheters be replaced after five(5) minutes of total use. Thus, by viewing digital readout 76, the user may readily ascertain the time remaining in the useful life of the ultrasound catheter.
SiiS~E~ (aU~ Z6~
WO 95/09572 ~ PCTIUS94/11060 For example, status indicator 78 may illuminate to indicate an operational condition of the ultrasound catheter. That is, status indicator 78 illuminates when ultrasound energy is being transmitted through the ultrasound transmission member 11.
As a further example, status indicator 80 may illuminate during the intermittent off-period of the ultrasound catheter 10. Contemporary protocol requires a five second off-period after each thirty seconds of to ultrasonic energy applied.
As a still further example, status indicator 82 may illuminate to indicate that the catheter life has expired, i.e., five minutes of total time has accumulated during which ultrasound energy has been applied through the ultrasound transmission member 11.
Down 84 and up 86 membrane switches facilitate cycling between three different modes of operation. The selected mode of operation is indicated by digital indicator 88.
Each time either the down 84 or the up 86 membrane switch is pushed, the selected mode of operation changes.
The irrigation mode is indicated by an "I" displayed in digital indicator 88. Cooling fluid, typically saline, is provided through ultrasound catheter 10 and no ultrasonic energy is applied when the irrigation mode is selected.
The peripheral mode is indicated by a "P" displayed in the digital indicator 88. When the peripheral mode of operation is selected, appropriate feedback control is maintained. Feedback control during peripheral mode operation may vary from that which is employed during coronary mode operation. Indeed, various different modes of operation may be selected wherein each different mode of operation corresponds to a different type of feedback control. Differences in feedback control may be provided to accommodate differences in catheter length, tip size, and power density required at the catheter tip.
StIBSTI~Ut'E SHEET (HUIE I6) WO 95!09572 PCT/US94/11060 The cardiac mode is indicated by a "C". Feedback control is provided so as to optimize ablation effectiveness while maintaining the ultrasound output level within protocol limits. The effects of sharp bends occurring in the tortuous path from the femoral artery to the coronary arteries, for example, are mitigated.
It will be recognized by those skilled in the art that the feedback control signal may comprise a variety of different signals generated by a variety of different means. For example, the feedback control signal may comprise the ultrasound transducer current level.
Alternatively, the feedback control signal may comprise a signal generated by a vibration transducer mounted at the distal tip of the ultrasound catheter so as to directly measure ultrasonic vibration thereof.
Referring now to Figure 7, a block diagram of the signal generation and control electronics 16 is provided.
A foot switch 100 controls the generation of an unmodulated transducer drive signal via the source voltage supply 102.
The unmodulated transducer drive signal is provided by the source voltage supply 102 to a modulator 104. A modulating signal, preferably a sine wave, is provided by the modulating signal source 106 to the modulator 104 where modulation of the transducer drive signal is effected thereby. The modulator 104 provides a modulated transducer drive signal to the ultrasound transducer 108.
The current provided to the ultrasound transducer 108 is monitored by the current monitor 110, the output of which is used by the feedback control 112 to effect variations in the output of the source voltage supply 102, as required. Status indicator 113 (corresponding to status indicator 78 of Figure 6) provides an indication of when feedback control is being utilized to effect changes in the output of the source voltage supply 102.
Sensing of the transducer current is preferably accomplished via a sensing transformer intermediate the SStII~STtilIT~ ~i'EE~' (RillE 26~
source voltage power supply and the piezo-ceramic elements of the ultrasound transducer. In the preferred embodiment of the present invention, the secondary of this sensing transformer supplies a signal to a peak detector through a half-wave rectifier and low pass filter. The resulting signal is fed to an error amplifier having a gain setting of approximately ten. The error amplifier is in communication with the pulse width modular, window comparators, level shifters and push-pull MOSFET stage.
This train of circuitry adjusts the DC voltage supply downward until the error amplifier signal is minimized.
Thus, the output of the ultrasound transducer is maintained within an established range, i.e., above a level of minimum efficacy and below an upper threshold beyond which operation is limited by protocol.
The front panel indicator of the transducer feedback control is connected to a comparator which is AND
functioned with a square wave signal having a frequency of approximately 6Hz. The comparator changes state when the system is within a pre-determined margin of controlling the DC source voltage. This margin is changeable depending upon the type of catheter being driven.
The irrigate only/cardiac/peripheral selector 114 is utilized to select the desired mode of operation, i.e., irrigate only, cardiac, or peripheral.
Thirty-second timer/five-second timer 116 applies the output of the modulator 104 to the ultrasound transducer 108 according to contemporary protocol such that each thirty seconds of ultrasound energy applied through the ultrasound catheter 10 is followed by five seconds of off time. Rest/active indicator 118 (corresponding to status indicator 80 of Figure 6) provides an indication of whether the ultrasound catheter is in the thirty-second on time or the five-second off period.
The five accumulated minutes timer 120 discontinues the application of ultrasound energy after five(5) minutes ' SUBSTITUTE SHEET (RULE 2G) WO 95/09572 ~ PCT/US94/11060 of total time have accumulated for a particular ultrasound catheter 10. The timer must be manually reset so as to confirm that the ultrasound catheter 10 has been replaced.
Catheter indicator 122 (corresponding to status indicator 82 of Figure 6) provides a quick visual indication of the status of the catheter, i.e., whether or not five(5) accumulated minutes have elapsed. The catheter accumulated time display 124 (corresponding to distal readout 76 of Figure 6) provides a visual indication of the time remaining for operation of the ultrasound catheter 10.
The ultrasound transmission member breakage detector 109 provides a breakage alarm, either via status indicator 112 or via a separate dedicated alarm, in the event that any comparison of the drive energy to the induced feedback control signal indicates that the desired ultrasonic vibration has been reached at a drive energy level less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
Now referring to Figure 8, operation of the ultrasound catheter having modulated output with feedback control of the present invention is illustrated. The user first selects the irrigation mode 200, then depresses the foot pedal to initiate irrigation 202, as desired. Next, either the cardiac or peripheral mode of operation 204 is selected.
If the cardiac mode of operation is selected, the ablation procedure 207 is performed with feedback control.
If the peripheral mode of operation is selected, then the ablation procedure is performed 206 with a different amount of total power delivered to the catheter and with different feedback control, if desired. A solid status light 78 (Figure 6) indicates effective driving of the transmission member by the transducer and a blinking status light 78 indicates ineffective driving of the transmission member.
~us~~ (sup 2~~
WO 95!09572 PCT/US94/11060 In either the peripheral or cardiac mode of operation, the output of the source voltage supply is modulated so as to facilitate adequate cooling of the ultrasound catheter while minimizing stresses placed thereupon due to abrupt 5 accelerations as occurs in the prior art.
If the status light 78 blinks 208 then the ultrasound transmission member may be checked for proper connection 210 and/or potentially manipulated so as to provide for the better transmission of ultrasound energy, i.e., by 10 manipulating the ultrasound catheter so as to loosen any bends therein, where possible. As long as the status light does not blink 208, then the procedure proceeds according to protocol wherein thirty-seconds of operation are followed by five-seconds of off-time 212. If the status light continues to blink, such blinking may be an indication of a break or fracture of the transmission member and appropriate measures may be undertaken to replace the catheter before continuing.
Alternatively, a separate indicator may be provided to specifically indicate breakage of the ultrasound transmission member. Such breakage would be detected by sensing the presence of a desired feedback current when less than the normally required drive signal is provided.
The procedure may continue until the catheter life expired indicator 82 (Figure 6) indicates that five minutes of total time have accumulated 214 on the catheter in use.
The old catheter must be removed and a new catheter utilized prior to proceeding.
Thus, thermal build-up within the ultrasound catheter is controlled by optimizing the duty cycle of the transducer drive signal such that maximum ablation is achieved with acceptable thermal build-up.
Additionally, the wave form of the transducer drive signal can be optimized so as to provide effective ablation upon a wide range of body tissue, plaque, clots, thrombus, etc. ' s~'~ (au~ Zs) ~I'~344~
WO 95/09572 ~ , , PCT/US94/11060 p..
For example, a variety of different pre-programmed combinations of modulated signal function and source voltage amplitude may optionally be provided so as to optimize the application of ultrasound energy for a selected therapeutic function.
Breakage of the ultrasound transmission member may be optionally be detected. Differences in the feedback signal provided when the ultrasound catheter binds, i.e., due to excessive bending, and when the ultrasound transmission member fractures or is broken facilitate electronic differentiation between these two conditions. When the ultrasound transmission member binds, the feedback current decreases and in response to this decrease in the fee aback current signal, the source voltage is increased. However, in the instance of ultrasound transmission member breakage, a normal feedback current signal is generated with the application of a substantially reduced source voltage. The normal feedback current signal results since it is possible to drive the shorter length of the broken ultrasound transmission member with less than the normally required source voltage. Detection of this condition makes it possible to indicate breakage of the ultrasound transmission member to the user so that the procedure may be halted and a new catheter provided.
Those skilled in the art will recognize that breakage of the ultrasound transmission member typically occurs within a few ultrasound modes of the ultrasound transducer, where ultrasound energy density concentration is the greatest. Thus, the difference in the source voltage required to drive a normal, i.e., unbroken, ultrasound transmission member and that required to drive a much shorter broken ultrasound transmission member is substantial.
It is understood that the exemplary method and apparatus for removing obstructions from anatomical structures described herein and shown in the drawings su~~ leu~zs~
WO 95/09572 PCT/US94/ilOGO
represents only a presently preferred embodiment of the invention. Indeed, various modifications and additions may be made to such embodiment without departing from the spirit and scope of the invention. For example the means for modulating the transducer drive signal with the modulating signal may comprise a variety type of circuits utilizing various solid state devices, vacuum tubes, and/or microprocessor means. Also, those skilled in the art will recognize that various thresholds for effecting changes in the output of the source voltage supply 102 in response to the input to the ultrasound transducer 108 are suitable, depending upon the physical characteristics of the ultrasound catheter, and the ultrasound energy requirements of the particular procedure being performed. Thus, these and other modifications and additions may be obvious to those skilled in the art and may be implemented to adapt the present invention for use in a variety of different applications.
suesntutE s~ (au~ zs)
Claims (13)
1. A method for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, said method characterized by the steps of:
providing a modulating signal that is substantially continuously varying in amplitude and is continuous in duration; and applying the modulating signal to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal, wherein the resulting modulated ultrasound transducer drive signal is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency.
providing a modulating signal that is substantially continuously varying in amplitude and is continuous in duration; and applying the modulating signal to an ultrasound transducer drive signal so as to modulate the ultrasound transducer drive signal, wherein the resulting modulated ultrasound transducer drive signal is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency.
2. The method according to claim 1 further characterized in that the modulating signal comprises a sine wave.
3. The method according to either of claims 1 or 2 further characterized by the steps of:
monitoring the current of the modulated ultrasonic transducer drive signal;
and varying the amplitude of the voltage of the modulated ultrasonic transducer drive signal in response to changes in the current thereof, wherein varying the amplitude of the voltage of the modulated ultrasonic transducer drive signal in response to changes in the current thereof enhances ablation by reducing undesirable variations in ultrasound energy used therefor.
monitoring the current of the modulated ultrasonic transducer drive signal;
and varying the amplitude of the voltage of the modulated ultrasonic transducer drive signal in response to changes in the current thereof, wherein varying the amplitude of the voltage of the modulated ultrasonic transducer drive signal in response to changes in the current thereof enhances ablation by reducing undesirable variations in ultrasound energy used therefor.
4. The method according to any of claims 1, 2, or 3 further characterized by:
measuring a feedback control signal representing the ultrasonic vibration at the distal end of the ultrasound transmission member;
defining the minimal drive energy typically required to obtain a desired induced feedback control signal when the ultrasound transmission member is unbroken;
periodically or continually comparing the drive energy being delivered to the induced feedback control signal being received; and providing a breakage alarm in the event that any comparison of the drive energy of the induced feedback control signal indicates that said desired ultrasonic vibration has been reached at a drive energy level less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
measuring a feedback control signal representing the ultrasonic vibration at the distal end of the ultrasound transmission member;
defining the minimal drive energy typically required to obtain a desired induced feedback control signal when the ultrasound transmission member is unbroken;
periodically or continually comparing the drive energy being delivered to the induced feedback control signal being received; and providing a breakage alarm in the event that any comparison of the drive energy of the induced feedback control signal indicates that said desired ultrasonic vibration has been reached at a drive energy level less than the minimum drive energy level typically required for such desired ultrasound vibration when the ultrasound transmission member is intact.
5. The method according to any preceding claim further characterized in that the modulating signal is an optimized function so as to optimize the application of ultrasonic energy by the ultrasound transmission member for a particular application.
6. The method according to any preceding claim further characterized in that the modulating signal is selectable from a plurality of different modulating signals, each of the different modulating signals being an optimized function for a particular application.
7. The method according to any preceding claim further characterized in that the modulating signal is optimized for at least one particular application selected from the list consisting of:
a) ablation of atherosclerotic plaque; and b) ablation of thrombotic matter.
a) ablation of atherosclerotic plaque; and b) ablation of thrombotic matter.
8. An apparatus for driving an ultrasound transducer coupled to an ultrasound transmission member extending longitudinally through an ultrasound catheter such that the distal end of the ultrasound transmission member oscillates at a desired operational ultrasound frequency, the apparatus characterized by:
a drive signal generator connected to the ultrasound transducer, the drive signal generator being responsive to a modulating signal to provide the transducer with a modulated ultrasound transducer drive signal that is substantially continuously varying in amplitude and is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency; and the ultrasound transducer receiving the modulated ultrasound transducer drive signal and being responsive thereto to provide an ultrasound output;
whereby the ultrasound transmission member coupled to the transducer is responsive to the ultrasound output to provide ultrasound energy at its distal end.
a drive signal generator connected to the ultrasound transducer, the drive signal generator being responsive to a modulating signal to provide the transducer with a modulated ultrasound transducer drive signal that is substantially continuously varying in amplitude and is continuous in duration and devoid of high frequency components which exceed the desired operational ultrasound frequency; and the ultrasound transducer receiving the modulated ultrasound transducer drive signal and being responsive thereto to provide an ultrasound output;
whereby the ultrasound transmission member coupled to the transducer is responsive to the ultrasound output to provide ultrasound energy at its distal end.
9. The apparatus according to claim 8 further characterized in that the drive signal generator comprises:
a modulating signal generator for providing the modulating signal that is substantially continuously varying in amplitude and is continuous in duration;
an ultrasound transducer drive signal generator for providing an ultrasound drive signal;
and a modulator for applying the modulating signal to the drive signal so as to generate a modulated ultrasound transducer drive signal.
a modulating signal generator for providing the modulating signal that is substantially continuously varying in amplitude and is continuous in duration;
an ultrasound transducer drive signal generator for providing an ultrasound drive signal;
and a modulator for applying the modulating signal to the drive signal so as to generate a modulated ultrasound transducer drive signal.
10. The apparatus according to either of claims 8 or 9 further characterized by a display for displaying information regarding the modulated ultrasound transducer drive signal.
11. The apparatus according to any of claims 8, 9, or 10 further characterized by:
a current sensor for sensing current of the modulated ultrasound transducer drive signal;
and a feedback control for varying the voltage of the ultrasound transducer drive signal in response to changes in power delivered at the distal tip of the ultrasound transmission member.
a current sensor for sensing current of the modulated ultrasound transducer drive signal;
and a feedback control for varying the voltage of the ultrasound transducer drive signal in response to changes in power delivered at the distal tip of the ultrasound transmission member.
12. The apparatus according to any of claims 8,9,10,or 11 further characterized in that the drive signal generator is responsive to a modulating signal comprises a sine wave.
13. The apparatus according to any of claims 8,9,10,11,or 12 further characterized by:
measuring a feedback control signal representing the ultrasonic vibration at the distal end of the ultrasound transmission member; and a feedback control compares the measured feedback control signal to the drive energy and provides a breakage alarm if the drive energy is below a level typically required for the level of vibration measured.
measuring a feedback control signal representing the ultrasonic vibration at the distal end of the ultrasound transmission member; and a feedback control compares the measured feedback control signal to the drive energy and provides a breakage alarm if the drive energy is below a level typically required for the level of vibration measured.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/131,796 US5447509A (en) | 1991-01-11 | 1993-10-04 | Ultrasound catheter system having modulated output with feedback control |
US08/131,796 | 1993-10-04 | ||
PCT/US1994/011060 WO1995009572A1 (en) | 1993-10-04 | 1994-09-30 | Ultrasound catheter system having modulated output with feedback control |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2173446A1 CA2173446A1 (en) | 1995-04-13 |
CA2173446C true CA2173446C (en) | 2001-05-08 |
Family
ID=22451061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002173446A Expired - Fee Related CA2173446C (en) | 1993-10-04 | 1994-09-30 | Ultrasound catheter system having modulated output with feedback control |
Country Status (7)
Country | Link |
---|---|
US (1) | US5447509A (en) |
EP (1) | EP0722295B1 (en) |
JP (1) | JP2811123B2 (en) |
AT (1) | ATE236579T1 (en) |
CA (1) | CA2173446C (en) |
DE (1) | DE69432469T2 (en) |
WO (1) | WO1995009572A1 (en) |
Families Citing this family (366)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US5628743A (en) * | 1994-12-21 | 1997-05-13 | Valleylab Inc. | Dual mode ultrasonic surgical apparatus |
US6176842B1 (en) | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6210356B1 (en) | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
EP0821567B1 (en) * | 1995-04-17 | 2004-03-24 | W. Gregory Chernoff | Surgical apparatus |
US5735280A (en) * | 1995-05-02 | 1998-04-07 | Heart Rhythm Technologies, Inc. | Ultrasound energy delivery system and method |
EP0957792A4 (en) * | 1995-05-02 | 2000-09-20 | Heart Rhythm Tech Inc | System for controlling the energy delivered to a patient for ablation |
DE69513506T2 (en) | 1995-05-26 | 2000-03-30 | Schneider Europ Gmbh Buelach | A stent expansion system using a pulsed flow medium |
US5728062A (en) * | 1995-11-30 | 1998-03-17 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US5735811A (en) * | 1995-11-30 | 1998-04-07 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced fluid delivery |
US5725494A (en) * | 1995-11-30 | 1998-03-10 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced intraluminal therapy |
US5656016A (en) * | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
US5788668A (en) * | 1996-05-09 | 1998-08-04 | World Medical Manufacturing Corporation | Vibrational enhancement of intravenous gas exchanging devices and long-term intravenous devices |
US6464660B2 (en) | 1996-09-05 | 2002-10-15 | Pharmasonics, Inc. | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US5846218A (en) | 1996-09-05 | 1998-12-08 | Pharmasonics, Inc. | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US6719755B2 (en) * | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US6221038B1 (en) | 1996-11-27 | 2001-04-24 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US5853368A (en) * | 1996-12-23 | 1998-12-29 | Hewlett-Packard Company | Ultrasound imaging catheter having an independently-controllable treatment structure |
US5722979A (en) * | 1997-04-08 | 1998-03-03 | Schneider (Usa) Inc. | Pressure assisted ultrasonic balloon catheter and method of using same |
WO1998048711A1 (en) * | 1997-05-01 | 1998-11-05 | Ekos Corporation | Ultrasound catheter |
US6723063B1 (en) | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6676626B1 (en) * | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US5931805A (en) * | 1997-06-02 | 1999-08-03 | Pharmasonics, Inc. | Catheters comprising bending transducers and methods for their use |
US6228046B1 (en) | 1997-06-02 | 2001-05-08 | Pharmasonics, Inc. | Catheters comprising a plurality of oscillators and methods for their use |
US6053906A (en) * | 1997-06-25 | 2000-04-25 | Olympus Optical Co., Ltd. | Ultrasonic operation apparatus |
US6966908B2 (en) | 1997-07-08 | 2005-11-22 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6997925B2 (en) | 1997-07-08 | 2006-02-14 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6164283A (en) * | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6869431B2 (en) | 1997-07-08 | 2005-03-22 | Atrionix, Inc. | Medical device with sensor cooperating with expandable member |
US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6245064B1 (en) | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
US6538739B1 (en) | 1997-09-30 | 2003-03-25 | The Regents Of The University Of California | Bubble diagnostics |
US6312402B1 (en) | 1998-09-24 | 2001-11-06 | Ekos Corporation | Ultrasound catheter for improving blood flow to the heart |
US6607502B1 (en) | 1998-11-25 | 2003-08-19 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US8506519B2 (en) | 1999-02-16 | 2013-08-13 | Flowcardia, Inc. | Pre-shaped therapeutic catheter |
US20040024393A1 (en) * | 2002-08-02 | 2004-02-05 | Henry Nita | Therapeutic ultrasound system |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6758830B1 (en) | 1999-05-11 | 2004-07-06 | Atrionix, Inc. | Catheter positioning system |
US6660013B2 (en) * | 1999-10-05 | 2003-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus for removing plaque from blood vessels using ultrasonic energy |
US6733451B2 (en) | 1999-10-05 | 2004-05-11 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic probe used with a pharmacological agent |
US20030236539A1 (en) * | 1999-10-05 | 2003-12-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method for using an ultrasonic probe to clear a vascular access device |
US20050096669A1 (en) * | 1999-10-05 | 2005-05-05 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat coronary thrombus bearing lesions |
US20040097996A1 (en) | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
US20050043629A1 (en) * | 1999-10-05 | 2005-02-24 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device having a probe with a small proximal end |
US6695782B2 (en) | 1999-10-05 | 2004-02-24 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means |
US20030065263A1 (en) * | 1999-10-05 | 2003-04-03 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means having a line contact collet |
US20050119679A1 (en) * | 1999-10-05 | 2005-06-02 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat chronic total occlusions |
US6551337B1 (en) | 1999-10-05 | 2003-04-22 | Omnisonics Medical Technologies, Inc. | Ultrasonic medical device operating in a transverse mode |
US20050043753A1 (en) * | 1999-10-05 | 2005-02-24 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat peripheral artery disease |
US20040249401A1 (en) * | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
US6413254B1 (en) | 2000-01-19 | 2002-07-02 | Medtronic Xomed, Inc. | Method of tongue reduction by thermal ablation using high intensity focused ultrasound |
US6409720B1 (en) | 2000-01-19 | 2002-06-25 | Medtronic Xomed, Inc. | Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US6692450B1 (en) | 2000-01-19 | 2004-02-17 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same |
US6595934B1 (en) | 2000-01-19 | 2003-07-22 | Medtronic Xomed, Inc. | Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US6361531B1 (en) | 2000-01-21 | 2002-03-26 | Medtronic Xomed, Inc. | Focused ultrasound ablation devices having malleable handle shafts and methods of using the same |
US6392327B1 (en) | 2000-03-29 | 2002-05-21 | James L. Sackrison | Sonic transducer and feedback control method thereof |
JP4754148B2 (en) | 2000-05-16 | 2011-08-24 | アトリオニックス・インコーポレイテッド | Apparatus and method for incorporating an ultrasonic transducer into a delivery member |
WO2001095820A1 (en) | 2000-06-13 | 2001-12-20 | Atrionix, Inc. | Surgical ablation probe for forming a circumferential lesion |
US6537291B2 (en) * | 2000-10-20 | 2003-03-25 | Ethicon Endo-Surgery, Inc. | Method for detecting a loose blade in a hand piece connected to an ultrasonic surgical system |
US6633234B2 (en) | 2000-10-20 | 2003-10-14 | Ethicon Endo-Surgery, Inc. | Method for detecting blade breakage using rate and/or impedance information |
US6662127B2 (en) * | 2000-10-20 | 2003-12-09 | Ethicon Endo-Surgery, Inc. | Method for detecting presence of a blade in an ultrasonic system |
EP1330193A4 (en) * | 2000-11-02 | 2006-03-22 | Keith L March | Method and system for modulation of oscillating signals to enhance biologic effects |
US11229472B2 (en) | 2001-06-12 | 2022-01-25 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with multiple magnetic position sensors |
US20070060864A1 (en) * | 2001-08-24 | 2007-03-15 | Redding Bruce K | Skin treatment method and system |
US20040019318A1 (en) * | 2001-11-07 | 2004-01-29 | Wilson Richard R. | Ultrasound assembly for use with a catheter |
AU2002359576A1 (en) | 2001-12-03 | 2003-06-17 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
AU2002353016A1 (en) | 2001-12-03 | 2003-06-17 | Ekos Corporation | Small vessel ultrasound catheter |
JP4167178B2 (en) * | 2001-12-14 | 2008-10-15 | イコス コーポレイション | Determination of resumption of blood flow |
US6958040B2 (en) * | 2001-12-28 | 2005-10-25 | Ekos Corporation | Multi-resonant ultrasonic catheter |
EP1465701A4 (en) | 2002-01-15 | 2008-08-13 | Univ California | System and method providing directional ultrasound therapy to skeletal joints |
US7819826B2 (en) | 2002-01-23 | 2010-10-26 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
US20040068189A1 (en) * | 2002-02-28 | 2004-04-08 | Wilson Richard R. | Ultrasound catheter with embedded conductors |
US6819027B2 (en) * | 2002-03-04 | 2004-11-16 | Cepheid | Method and apparatus for controlling ultrasonic transducer |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8133236B2 (en) | 2006-11-07 | 2012-03-13 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7604608B2 (en) | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US7258690B2 (en) | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
US6907884B2 (en) | 2002-09-30 | 2005-06-21 | Depay Acromed, Inc. | Method of straddling an intraosseous nerve |
US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
US7771372B2 (en) | 2003-01-03 | 2010-08-10 | Ekos Corporation | Ultrasonic catheter with axial energy field |
WO2004093656A2 (en) | 2003-04-22 | 2004-11-04 | Ekos Corporation | Ultrasound enhanced central venous catheter |
US7291146B2 (en) | 2003-09-12 | 2007-11-06 | Minnow Medical, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
EP1713537A4 (en) | 2004-01-29 | 2009-04-29 | Ekos Corp | Method and apparatus for detecting vascular conditions with a catheter |
US7794414B2 (en) | 2004-02-09 | 2010-09-14 | Emigrant Bank, N.A. | Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes |
US8182501B2 (en) | 2004-02-27 | 2012-05-22 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical shears and method for sealing a blood vessel using same |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7338450B2 (en) * | 2004-08-27 | 2008-03-04 | General Electric Company | Method and apparatus for performing CW doppler ultrasound utilizing a 2D matrix array |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
PL1802245T3 (en) | 2004-10-08 | 2017-01-31 | Ethicon Endosurgery Llc | Ultrasonic surgical instrument |
US20060184070A1 (en) * | 2004-11-12 | 2006-08-17 | Hansmann Douglas R | External ultrasonic therapy |
JP2008521547A (en) * | 2004-11-30 | 2008-06-26 | オムニソニックス メディカル テクノロジーズ インコーポレイテッド | Ultrasonic medical equipment with variable frequency drive |
JP2006158525A (en) * | 2004-12-03 | 2006-06-22 | Olympus Medical Systems Corp | Ultrasonic surgical apparatus, and method of driving ultrasonic treatment instrument |
US20060173387A1 (en) * | 2004-12-10 | 2006-08-03 | Douglas Hansmann | Externally enhanced ultrasonic therapy |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
WO2007028114A2 (en) * | 2005-09-02 | 2007-03-08 | Encapsulation Systems, Inc. | Wound treatment method and system |
US20070066978A1 (en) * | 2005-09-06 | 2007-03-22 | Schafer Mark E | Ultrasound medical devices and related methods |
US20070191713A1 (en) | 2005-10-14 | 2007-08-16 | Eichmann Stephen E | Ultrasonic device for cutting and coagulating |
US7621930B2 (en) | 2006-01-20 | 2009-11-24 | Ethicon Endo-Surgery, Inc. | Ultrasound medical instrument having a medical ultrasonic blade |
US9282984B2 (en) | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US20070265560A1 (en) | 2006-04-24 | 2007-11-15 | Ekos Corporation | Ultrasound Therapy System |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
EP2954868A1 (en) | 2006-10-18 | 2015-12-16 | Vessix Vascular, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US8192363B2 (en) | 2006-10-27 | 2012-06-05 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
EP2526880A3 (en) | 2007-01-08 | 2013-02-20 | Ekos Corporation | Power parameters for ultrasonic catheter |
US8057498B2 (en) | 2007-11-30 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instrument blades |
US20080234709A1 (en) | 2007-03-22 | 2008-09-25 | Houser Kevin L | Ultrasonic surgical instrument and cartilage and bone shaping blades therefor |
US8911460B2 (en) | 2007-03-22 | 2014-12-16 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments |
US8142461B2 (en) | 2007-03-22 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Surgical instruments |
US8226675B2 (en) | 2007-03-22 | 2012-07-24 | Ethicon Endo-Surgery, Inc. | Surgical instruments |
ES2471118T3 (en) | 2007-06-22 | 2014-06-25 | Ekos Corporation | Method and apparatus for the treatment of intracranial hemorrhages |
US8882791B2 (en) | 2007-07-27 | 2014-11-11 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments |
US8808319B2 (en) | 2007-07-27 | 2014-08-19 | Ethicon Endo-Surgery, Inc. | Surgical instruments |
US8523889B2 (en) | 2007-07-27 | 2013-09-03 | Ethicon Endo-Surgery, Inc. | Ultrasonic end effectors with increased active length |
US9044261B2 (en) | 2007-07-31 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Temperature controlled ultrasonic surgical instruments |
US8252012B2 (en) * | 2007-07-31 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instrument with modulator |
US8512365B2 (en) | 2007-07-31 | 2013-08-20 | Ethicon Endo-Surgery, Inc. | Surgical instruments |
US8430898B2 (en) | 2007-07-31 | 2013-04-30 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments |
JP2010540160A (en) | 2007-10-05 | 2010-12-24 | マッケ カーディオバスキュラー,エルエルシー | Apparatus and method for minimally invasive surgical procedures |
JP2010540186A (en) | 2007-10-05 | 2010-12-24 | エシコン・エンド−サージェリィ・インコーポレイテッド | Ergonomic surgical instrument |
US10010339B2 (en) | 2007-11-30 | 2018-07-03 | Ethicon Llc | Ultrasonic surgical blades |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
CN102056546B (en) * | 2008-06-05 | 2014-01-01 | 株式会社日立医疗器械 | Ultrasonic diagnosing apparatus |
US9089360B2 (en) | 2008-08-06 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Devices and techniques for cutting and coagulating tissue |
US8058771B2 (en) | 2008-08-06 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Ultrasonic device for cutting and coagulating with stepped output |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
AU2009293019A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care Inc. | Solute concentration measurement device and related methods |
EP3406210A1 (en) | 2008-09-26 | 2018-11-28 | Relievant Medsystems, Inc. | Systems and for navigating an instrument through bone |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
CN101869499B (en) | 2009-04-27 | 2012-02-08 | 宋源 | Perturbed single-conduit surgical instrument |
US9700339B2 (en) | 2009-05-20 | 2017-07-11 | Ethicon Endo-Surgery, Inc. | Coupling arrangements and methods for attaching tools to ultrasonic surgical instruments |
US8226566B2 (en) | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
US8344596B2 (en) | 2009-06-24 | 2013-01-01 | Ethicon Endo-Surgery, Inc. | Transducer arrangements for ultrasonic surgical instruments |
EP2448636B1 (en) | 2009-07-03 | 2014-06-18 | Ekos Corporation | Power parameters for ultrasonic catheter |
US8461744B2 (en) | 2009-07-15 | 2013-06-11 | Ethicon Endo-Surgery, Inc. | Rotating transducer mount for ultrasonic surgical instruments |
US8663220B2 (en) | 2009-07-15 | 2014-03-04 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments |
US9017326B2 (en) | 2009-07-15 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Impedance monitoring apparatus, system, and method for ultrasonic surgical instruments |
CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US8255180B2 (en) * | 2009-08-11 | 2012-08-28 | Santec Systems Inc. | Acoustography dynamic range extending device and method |
USRE47996E1 (en) | 2009-10-09 | 2020-05-19 | Ethicon Llc | Surgical generator for ultrasonic and electrosurgical devices |
US11090104B2 (en) | 2009-10-09 | 2021-08-17 | Cilag Gmbh International | Surgical generator for ultrasonic and electrosurgical devices |
US10441345B2 (en) | 2009-10-09 | 2019-10-15 | Ethicon Llc | Surgical generator for ultrasonic and electrosurgical devices |
US9168054B2 (en) | 2009-10-09 | 2015-10-27 | Ethicon Endo-Surgery, Inc. | Surgical generator for ultrasonic and electrosurgical devices |
US8956349B2 (en) | 2009-10-09 | 2015-02-17 | Ethicon Endo-Surgery, Inc. | Surgical generator for ultrasonic and electrosurgical devices |
US8486096B2 (en) | 2010-02-11 | 2013-07-16 | Ethicon Endo-Surgery, Inc. | Dual purpose surgical instrument for cutting and coagulating tissue |
US8961547B2 (en) | 2010-02-11 | 2015-02-24 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments with moving cutting implement |
US8951272B2 (en) | 2010-02-11 | 2015-02-10 | Ethicon Endo-Surgery, Inc. | Seal arrangements for ultrasonically powered surgical instruments |
US8469981B2 (en) | 2010-02-11 | 2013-06-25 | Ethicon Endo-Surgery, Inc. | Rotatable cutting implement arrangements for ultrasonic surgical instruments |
US8531064B2 (en) | 2010-02-11 | 2013-09-10 | Ethicon Endo-Surgery, Inc. | Ultrasonically powered surgical instruments with rotating cutting implement |
US8579928B2 (en) | 2010-02-11 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Outer sheath and blade arrangements for ultrasonic surgical instruments |
US8740835B2 (en) | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
GB2480498A (en) | 2010-05-21 | 2011-11-23 | Ethicon Endo Surgery Inc | Medical device comprising RF circuitry |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
DE102010023910A1 (en) * | 2010-06-16 | 2011-12-22 | Hpf Gmbh | Apparatus and method for removing thrombi |
US8795327B2 (en) | 2010-07-22 | 2014-08-05 | Ethicon Endo-Surgery, Inc. | Electrosurgical instrument with separate closure and cutting members |
US9192431B2 (en) | 2010-07-23 | 2015-11-24 | Ethicon Endo-Surgery, Inc. | Electrosurgical cutting and sealing instrument |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
EP2608730B1 (en) | 2010-08-27 | 2019-07-24 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
US20120065506A1 (en) * | 2010-09-10 | 2012-03-15 | Scott Smith | Mechanical, Electromechanical, and/or Elastographic Assessment for Renal Nerve Ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9259265B2 (en) | 2011-07-22 | 2016-02-16 | Ethicon Endo-Surgery, Llc | Surgical instruments for tensioning tissue |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793690B1 (en) | 2011-12-23 | 2021-04-07 | Vessix Vascular, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
AU2012362524B2 (en) | 2011-12-30 | 2018-12-13 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
WO2013109269A1 (en) | 2012-01-18 | 2013-07-25 | Bard Peripheral Vascular, Inc. | Vascular re-entry device |
EP2811932B1 (en) | 2012-02-10 | 2019-06-26 | Ethicon LLC | Robotically controlled surgical instrument |
US9226766B2 (en) | 2012-04-09 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Serial communication protocol for medical device |
US9237921B2 (en) | 2012-04-09 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Devices and techniques for cutting and coagulating tissue |
US9439668B2 (en) | 2012-04-09 | 2016-09-13 | Ethicon Endo-Surgery, Llc | Switch arrangements for ultrasonic surgical instruments |
US9724118B2 (en) | 2012-04-09 | 2017-08-08 | Ethicon Endo-Surgery, Llc | Techniques for cutting and coagulating tissue for ultrasonic surgical instruments |
US9241731B2 (en) | 2012-04-09 | 2016-01-26 | Ethicon Endo-Surgery, Inc. | Rotatable electrical connection for ultrasonic surgical instruments |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US20140005705A1 (en) | 2012-06-29 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Surgical instruments with articulating shafts |
US9198714B2 (en) | 2012-06-29 | 2015-12-01 | Ethicon Endo-Surgery, Inc. | Haptic feedback devices for surgical robot |
US9820768B2 (en) | 2012-06-29 | 2017-11-21 | Ethicon Llc | Ultrasonic surgical instruments with control mechanisms |
US9351754B2 (en) | 2012-06-29 | 2016-05-31 | Ethicon Endo-Surgery, Llc | Ultrasonic surgical instruments with distally positioned jaw assemblies |
US9408622B2 (en) | 2012-06-29 | 2016-08-09 | Ethicon Endo-Surgery, Llc | Surgical instruments with articulating shafts |
US20140005702A1 (en) | 2012-06-29 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Ultrasonic surgical instruments with distally positioned transducers |
US9326788B2 (en) | 2012-06-29 | 2016-05-03 | Ethicon Endo-Surgery, Llc | Lockout mechanism for use with robotic electrosurgical device |
US9226767B2 (en) | 2012-06-29 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Closed feedback control for electrosurgical device |
US9393037B2 (en) | 2012-06-29 | 2016-07-19 | Ethicon Endo-Surgery, Llc | Surgical instruments with articulating shafts |
US9283045B2 (en) | 2012-06-29 | 2016-03-15 | Ethicon Endo-Surgery, Llc | Surgical instruments with fluid management system |
EP3895632A1 (en) * | 2012-08-02 | 2021-10-20 | Bard Peripheral Vascular, Inc. | Ultrasound catheter system |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
BR112015007010B1 (en) | 2012-09-28 | 2022-05-31 | Ethicon Endo-Surgery, Inc | end actuator |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US9173667B2 (en) | 2012-10-16 | 2015-11-03 | Med-Sonics Corporation | Apparatus and methods for transferring ultrasonic energy to a bodily tissue |
US10201365B2 (en) | 2012-10-22 | 2019-02-12 | Ethicon Llc | Surgeon feedback sensing and display methods |
US9095367B2 (en) | 2012-10-22 | 2015-08-04 | Ethicon Endo-Surgery, Inc. | Flexible harmonic waveguides/blades for surgical instruments |
EP3598952A3 (en) | 2012-11-05 | 2020-04-15 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone and modulating nerves within the bone |
US9339284B2 (en) | 2012-11-06 | 2016-05-17 | Med-Sonics Corporation | Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue |
US20140135804A1 (en) | 2012-11-15 | 2014-05-15 | Ethicon Endo-Surgery, Inc. | Ultrasonic and electrosurgical devices |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10226273B2 (en) | 2013-03-14 | 2019-03-12 | Ethicon Llc | Mechanical fasteners for use with surgical energy devices |
SG10201702432YA (en) | 2013-03-14 | 2017-05-30 | Ekos Corp | Method and apparatus for drug delivery to a target site |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US9241728B2 (en) | 2013-03-15 | 2016-01-26 | Ethicon Endo-Surgery, Inc. | Surgical instrument with multiple clamping mechanisms |
CN105473090B (en) | 2013-03-15 | 2019-05-03 | 波士顿科学国际有限公司 | Rebuild the method and device of the tissue of body passage or the tissue of neighbouring body passage |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
EP3010436A1 (en) | 2013-06-21 | 2016-04-27 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
WO2015006480A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
WO2015006573A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
CN105555220B (en) | 2013-07-22 | 2019-05-17 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
EP3035879A1 (en) | 2013-08-22 | 2016-06-29 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
EP3041425B1 (en) | 2013-09-04 | 2022-04-13 | Boston Scientific Scimed, Inc. | Radio frequency (rf) balloon catheter having flushing and cooling capability |
US9814514B2 (en) | 2013-09-13 | 2017-11-14 | Ethicon Llc | Electrosurgical (RF) medical instruments for cutting and coagulating tissue |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9504471B2 (en) | 2013-09-25 | 2016-11-29 | Cybersonics, Inc. | Ultrasonic generator systems and methods |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
JP2016534842A (en) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Embedded thermocouples in denervation flex circuits |
US9265926B2 (en) | 2013-11-08 | 2016-02-23 | Ethicon Endo-Surgery, Llc | Electrosurgical devices |
GB2521229A (en) | 2013-12-16 | 2015-06-17 | Ethicon Endo Surgery Inc | Medical device |
GB2521228A (en) | 2013-12-16 | 2015-06-17 | Ethicon Endo Surgery Inc | Medical device |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US9795436B2 (en) | 2014-01-07 | 2017-10-24 | Ethicon Llc | Harvesting energy from a surgical generator |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9554854B2 (en) | 2014-03-18 | 2017-01-31 | Ethicon Endo-Surgery, Llc | Detecting short circuits in electrosurgical medical devices |
US10463421B2 (en) | 2014-03-27 | 2019-11-05 | Ethicon Llc | Two stage trigger, clamp and cut bipolar vessel sealer |
US10092310B2 (en) | 2014-03-27 | 2018-10-09 | Ethicon Llc | Electrosurgical devices |
US9737355B2 (en) | 2014-03-31 | 2017-08-22 | Ethicon Llc | Controlling impedance rise in electrosurgical medical devices |
US9913680B2 (en) | 2014-04-15 | 2018-03-13 | Ethicon Llc | Software algorithms for electrosurgical instruments |
US10285724B2 (en) | 2014-07-31 | 2019-05-14 | Ethicon Llc | Actuation mechanisms and load adjustment assemblies for surgical instruments |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10639092B2 (en) | 2014-12-08 | 2020-05-05 | Ethicon Llc | Electrode configurations for surgical instruments |
US10245095B2 (en) | 2015-02-06 | 2019-04-02 | Ethicon Llc | Electrosurgical instrument with rotation and articulation mechanisms |
US10321950B2 (en) | 2015-03-17 | 2019-06-18 | Ethicon Llc | Managing tissue treatment |
US10342602B2 (en) | 2015-03-17 | 2019-07-09 | Ethicon Llc | Managing tissue treatment |
US10595929B2 (en) | 2015-03-24 | 2020-03-24 | Ethicon Llc | Surgical instruments with firing system overload protection mechanisms |
US9763684B2 (en) | 2015-04-02 | 2017-09-19 | Med-Sonics Corporation | Devices and methods for removing occlusions from a bodily cavity |
ITMI20150582A1 (en) * | 2015-04-23 | 2016-10-23 | Mdm Ind S R L | ELECTRONIC APPARATUS FOR RADIOFREQUENCY OR ULTRASOUND TREATMENTS AND RELATIVE METHOD. |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US10034684B2 (en) | 2015-06-15 | 2018-07-31 | Ethicon Llc | Apparatus and method for dissecting and coagulating tissue |
US11020140B2 (en) | 2015-06-17 | 2021-06-01 | Cilag Gmbh International | Ultrasonic surgical blade for use with ultrasonic surgical instruments |
US10357303B2 (en) | 2015-06-30 | 2019-07-23 | Ethicon Llc | Translatable outer tube for sealing using shielded lap chole dissector |
US11051873B2 (en) | 2015-06-30 | 2021-07-06 | Cilag Gmbh International | Surgical system with user adaptable techniques employing multiple energy modalities based on tissue parameters |
US11129669B2 (en) | 2015-06-30 | 2021-09-28 | Cilag Gmbh International | Surgical system with user adaptable techniques based on tissue type |
US10898256B2 (en) | 2015-06-30 | 2021-01-26 | Ethicon Llc | Surgical system with user adaptable techniques based on tissue impedance |
US10034704B2 (en) | 2015-06-30 | 2018-07-31 | Ethicon Llc | Surgical instrument with user adaptable algorithms |
US11141213B2 (en) | 2015-06-30 | 2021-10-12 | Cilag Gmbh International | Surgical instrument with user adaptable techniques |
US10154852B2 (en) | 2015-07-01 | 2018-12-18 | Ethicon Llc | Ultrasonic surgical blade with improved cutting and coagulation features |
US10687884B2 (en) | 2015-09-30 | 2020-06-23 | Ethicon Llc | Circuits for supplying isolated direct current (DC) voltage to surgical instruments |
US10595930B2 (en) | 2015-10-16 | 2020-03-24 | Ethicon Llc | Electrode wiping surgical device |
US10492141B2 (en) | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
US10179022B2 (en) | 2015-12-30 | 2019-01-15 | Ethicon Llc | Jaw position impedance limiter for electrosurgical instrument |
US10575892B2 (en) | 2015-12-31 | 2020-03-03 | Ethicon Llc | Adapter for electrical surgical instruments |
US11129670B2 (en) | 2016-01-15 | 2021-09-28 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with selective application of energy based on button displacement, intensity, or local tissue characterization |
US11229471B2 (en) | 2016-01-15 | 2022-01-25 | Cilag Gmbh International | Modular battery powered handheld surgical instrument with selective application of energy based on tissue characterization |
US10716615B2 (en) | 2016-01-15 | 2020-07-21 | Ethicon Llc | Modular battery powered handheld surgical instrument with curved end effectors having asymmetric engagement between jaw and blade |
US10709469B2 (en) | 2016-01-15 | 2020-07-14 | Ethicon Llc | Modular battery powered handheld surgical instrument with energy conservation techniques |
US10555769B2 (en) | 2016-02-22 | 2020-02-11 | Ethicon Llc | Flexible circuits for electrosurgical instrument |
US10646269B2 (en) | 2016-04-29 | 2020-05-12 | Ethicon Llc | Non-linear jaw gap for electrosurgical instruments |
US10702329B2 (en) | 2016-04-29 | 2020-07-07 | Ethicon Llc | Jaw structure with distal post for electrosurgical instruments |
US10485607B2 (en) | 2016-04-29 | 2019-11-26 | Ethicon Llc | Jaw structure with distal closure for electrosurgical instruments |
US10456193B2 (en) | 2016-05-03 | 2019-10-29 | Ethicon Llc | Medical device with a bilateral jaw configuration for nerve stimulation |
US10245064B2 (en) | 2016-07-12 | 2019-04-02 | Ethicon Llc | Ultrasonic surgical instrument with piezoelectric central lumen transducer |
US10893883B2 (en) | 2016-07-13 | 2021-01-19 | Ethicon Llc | Ultrasonic assembly for use with ultrasonic surgical instruments |
US10842522B2 (en) | 2016-07-15 | 2020-11-24 | Ethicon Llc | Ultrasonic surgical instruments having offset blades |
US10376305B2 (en) | 2016-08-05 | 2019-08-13 | Ethicon Llc | Methods and systems for advanced harmonic energy |
US10285723B2 (en) | 2016-08-09 | 2019-05-14 | Ethicon Llc | Ultrasonic surgical blade with improved heel portion |
USD847990S1 (en) | 2016-08-16 | 2019-05-07 | Ethicon Llc | Surgical instrument |
US10828056B2 (en) | 2016-08-25 | 2020-11-10 | Ethicon Llc | Ultrasonic transducer to waveguide acoustic coupling, connections, and configurations |
US10952759B2 (en) | 2016-08-25 | 2021-03-23 | Ethicon Llc | Tissue loading of a surgical instrument |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US10603064B2 (en) | 2016-11-28 | 2020-03-31 | Ethicon Llc | Ultrasonic transducer |
US11266430B2 (en) | 2016-11-29 | 2022-03-08 | Cilag Gmbh International | End effector control and calibration |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
EP3936140B1 (en) * | 2017-01-24 | 2023-08-30 | Boston Scientific Scimed, Inc. | Thrombolytic agent for the treatment of thromboembolism |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
US10820920B2 (en) | 2017-07-05 | 2020-11-03 | Ethicon Llc | Reusable ultrasonic medical devices and methods of their use |
CN111065342B (en) * | 2017-08-15 | 2023-07-04 | 皇家飞利浦有限公司 | Intracavity ultrasound device for diagnostic imaging and therapy |
AU2018434915A1 (en) | 2018-07-31 | 2021-01-28 | C.R. Bard, Inc. | Ultrasonic system and methods |
GB201906743D0 (en) * | 2019-05-13 | 2019-06-26 | Versono Medical Ltd | Compact uitrasonic endovascular occlusion crossing guidewire system |
JP2022543732A (en) * | 2019-06-18 | 2022-10-14 | シー・アール・バード・インコーポレーテッド | Ultrasound system and method with improved occlusion engagement during crossing and atherectomy procedures |
US10792054B1 (en) | 2019-07-11 | 2020-10-06 | Eduardo Lorenzo | Catheter for thromboembolic disease with mechanic waves, injection and ejection |
WO2021050767A1 (en) | 2019-09-12 | 2021-03-18 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
US20210196344A1 (en) | 2019-12-30 | 2021-07-01 | Ethicon Llc | Surgical system communication pathways |
US11779387B2 (en) | 2019-12-30 | 2023-10-10 | Cilag Gmbh International | Clamp arm jaw to minimize tissue sticking and improve tissue control |
US11660089B2 (en) | 2019-12-30 | 2023-05-30 | Cilag Gmbh International | Surgical instrument comprising a sensing system |
US20210196349A1 (en) | 2019-12-30 | 2021-07-01 | Ethicon Llc | Electrosurgical instrument with flexible wiring assemblies |
US20210196359A1 (en) | 2019-12-30 | 2021-07-01 | Ethicon Llc | Electrosurgical instruments with electrodes having energy focusing features |
US11786291B2 (en) | 2019-12-30 | 2023-10-17 | Cilag Gmbh International | Deflectable support of RF energy electrode with respect to opposing ultrasonic blade |
US11684412B2 (en) | 2019-12-30 | 2023-06-27 | Cilag Gmbh International | Surgical instrument with rotatable and articulatable surgical end effector |
US11779329B2 (en) | 2019-12-30 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a flex circuit including a sensor system |
US11944366B2 (en) | 2019-12-30 | 2024-04-02 | Cilag Gmbh International | Asymmetric segmented ultrasonic support pad for cooperative engagement with a movable RF electrode |
US11950797B2 (en) | 2019-12-30 | 2024-04-09 | Cilag Gmbh International | Deflectable electrode with higher distal bias relative to proximal bias |
US11911063B2 (en) | 2019-12-30 | 2024-02-27 | Cilag Gmbh International | Techniques for detecting ultrasonic blade to electrode contact and reducing power to ultrasonic blade |
US11452525B2 (en) | 2019-12-30 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising an adjustment system |
US20210196363A1 (en) | 2019-12-30 | 2021-07-01 | Ethicon Llc | Electrosurgical instrument with electrodes operable in bipolar and monopolar modes |
US11937863B2 (en) | 2019-12-30 | 2024-03-26 | Cilag Gmbh International | Deflectable electrode with variable compression bias along the length of the deflectable electrode |
US11812957B2 (en) | 2019-12-30 | 2023-11-14 | Cilag Gmbh International | Surgical instrument comprising a signal interference resolution system |
US11696776B2 (en) | 2019-12-30 | 2023-07-11 | Cilag Gmbh International | Articulatable surgical instrument |
EP4232131A1 (en) * | 2020-10-23 | 2023-08-30 | Vicora, Inc. | Actuated thrombectomy device |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3433226A (en) * | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
US3352303A (en) * | 1965-07-28 | 1967-11-14 | Lawrence J Delaney | Method for blood clot lysis |
US3526219A (en) * | 1967-07-21 | 1970-09-01 | Ultrasonic Systems | Method and apparatus for ultrasonically removing tissue from a biological organism |
NL145136C (en) * | 1967-07-25 | 1900-01-01 | ||
US3565062A (en) * | 1968-06-13 | 1971-02-23 | Ultrasonic Systems | Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like |
US3618594A (en) * | 1970-04-06 | 1971-11-09 | Surgical Design Corp | Ultrasonic apparatus for retinal reattachment |
US3809093A (en) * | 1972-04-14 | 1974-05-07 | S Abraham | Surgical tool |
DE2219790C3 (en) * | 1972-04-22 | 1974-11-07 | R Pohlman | Device for generating brittle fractures in hard stones |
US3861391A (en) * | 1972-07-02 | 1975-01-21 | Blackstone Corp | Apparatus for disintegration of urinary calculi |
US4188952A (en) * | 1973-12-28 | 1980-02-19 | Loschilov Vladimir I | Surgical instrument for ultrasonic separation of biological tissue |
SU569308A1 (en) * | 1975-06-27 | 1977-10-24 | Ростовский государственный медицинский институт | Device for ultrasonic surgery |
US4223676A (en) * | 1977-12-19 | 1980-09-23 | Cavitron Corporation | Ultrasonic aspirator |
US4214586A (en) * | 1978-11-30 | 1980-07-29 | Ethicon, Inc. | Anastomotic coupling device |
US4337090A (en) * | 1980-09-05 | 1982-06-29 | Raychem Corporation | Heat recoverable nickel/titanium alloy with improved stability and machinability |
US4366819A (en) * | 1980-11-17 | 1983-01-04 | Kaster Robert L | Anastomotic fitting |
US4800876A (en) * | 1981-12-11 | 1989-01-31 | Fox Kenneth R | Method of and apparatus for laser treatment of body lumens |
US4431006A (en) * | 1982-01-07 | 1984-02-14 | Technicare Corporation | Passive ultrasound needle probe locator |
US4565589A (en) * | 1982-03-05 | 1986-01-21 | Raychem Corporation | Nickel/titanium/copper shape memory alloy |
US4474180A (en) * | 1982-05-13 | 1984-10-02 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Apparatus for disintegrating kidney stones |
US5302115A (en) * | 1982-09-15 | 1994-04-12 | Damper Design, Inc. | Burner register assembly |
US4587958A (en) * | 1983-04-04 | 1986-05-13 | Sumitomo Bakelite Company Limited | Ultrasonic surgical device |
US4665906A (en) * | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4505767A (en) * | 1983-10-14 | 1985-03-19 | Raychem Corporation | Nickel/titanium/vanadium shape memory alloy |
CA1237482A (en) * | 1984-03-09 | 1988-05-31 | Frank B. Stiles | Catheter for effecting removal of obstructions from a biological duct |
US4979939A (en) * | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US4587972A (en) * | 1984-07-16 | 1986-05-13 | Morantte Jr Bernardo D | Device for diagnostic and therapeutic intravascular intervention |
US4960411A (en) * | 1984-09-18 | 1990-10-02 | Medtronic Versaflex, Inc. | Low profile sterrable soft-tip catheter |
US4589419A (en) * | 1984-11-01 | 1986-05-20 | University Of Iowa Research Foundation | Catheter for treating arterial occlusion |
US4750902A (en) * | 1985-08-28 | 1988-06-14 | Sonomed Technology, Inc. | Endoscopic ultrasonic aspirators |
US4922902A (en) * | 1986-05-19 | 1990-05-08 | Valleylab, Inc. | Method for removing cellular material with endoscopic ultrasonic aspirator |
US4957111A (en) * | 1985-09-13 | 1990-09-18 | Pfizer Hospital Products Group, Inc. | Method of using a doppler catheter |
US4924864A (en) * | 1985-11-15 | 1990-05-15 | Danzig Fred G | Apparatus and article for ligating blood vessels, nerves and other anatomical structures |
US4741731A (en) * | 1986-02-19 | 1988-05-03 | Fibra-Sonics, Inc. | Vented ultrasonic transducer for surgical handpiece |
US4794931A (en) * | 1986-02-28 | 1989-01-03 | Cardiovascular Imaging Systems, Inc. | Catheter apparatus, system and method for intravascular two-dimensional ultrasonography |
US4989588A (en) * | 1986-03-10 | 1991-02-05 | Olympus Optical Co., Ltd. | Medical treatment device utilizing ultrasonic wave |
US4827911A (en) * | 1986-04-02 | 1989-05-09 | Cooper Lasersonics, Inc. | Method and apparatus for ultrasonic surgical fragmentation and removal of tissue |
US4821731A (en) * | 1986-04-25 | 1989-04-18 | Intra-Sonix, Inc. | Acoustic image system and method |
US4867141A (en) * | 1986-06-18 | 1989-09-19 | Olympus Optical Co., Ltd. | Medical treatment apparatus utilizing ultrasonic wave |
US4764165A (en) * | 1986-07-17 | 1988-08-16 | Mentor O & O, Inc. | Ophthalmic aspirator-irrigator with valve |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
EP0293472B1 (en) * | 1986-11-27 | 1994-04-13 | Sumitomo Bakelite Company Limited | Ultrasonic surgical apparatus |
US4988356A (en) * | 1987-02-27 | 1991-01-29 | C. R. Bard, Inc. | Catheter and guidewire exchange system |
US4967753A (en) * | 1987-04-10 | 1990-11-06 | Cardiometrics, Inc. | Apparatus, system and method for measuring spatial average velocity and/or volumetric flow of blood in a vessel |
US4811743A (en) * | 1987-04-21 | 1989-03-14 | Cordis Corporation | Catheter guidewire |
DE3713560A1 (en) * | 1987-04-23 | 1988-11-03 | Escher Wyss Gmbh | CALENDAR WITH SLIDING BEARING PARTS |
US4841977A (en) * | 1987-05-26 | 1989-06-27 | Inter Therapy, Inc. | Ultra-thin acoustic transducer and balloon catheter using same in imaging array subassembly |
US4799496A (en) * | 1987-06-03 | 1989-01-24 | Lake Region Manufacturing Company, Inc. | Guide wire handle |
US4898575A (en) * | 1987-08-31 | 1990-02-06 | Medinnovations, Inc. | Guide wire following tunneling catheter system and method for transluminal arterial atherectomy |
US4917097A (en) * | 1987-10-27 | 1990-04-17 | Endosonics Corporation | Apparatus and method for imaging small cavities |
US4870953A (en) * | 1987-11-13 | 1989-10-03 | Donmicheal T Anthony | Intravascular ultrasonic catheter/probe and method for treating intravascular blockage |
US5163421A (en) * | 1988-01-22 | 1992-11-17 | Angiosonics, Inc. | In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging |
US4844092A (en) * | 1988-03-28 | 1989-07-04 | Schneider-Shiley (Usa) Inc. | Catheter Y-connector with guidewire locking means |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US4919133A (en) * | 1988-08-18 | 1990-04-24 | Chiang Tien Hon | Catheter apparatus employing shape memory alloy structures |
US4989583A (en) * | 1988-10-21 | 1991-02-05 | Nestle S.A. | Ultrasonic cutting tip assembly |
JPH071130Y2 (en) * | 1988-10-25 | 1995-01-18 | オリンパス光学工業株式会社 | Ultrasonic treatment device |
US4966583A (en) * | 1989-02-03 | 1990-10-30 | Elie Debbas | Apparatus for locating a breast mass |
US5061238A (en) * | 1989-02-23 | 1991-10-29 | Linvatec Corporation | Surgical cutting instrument with titanium nitride coating on an inner tubular member |
US4923441A (en) * | 1989-02-23 | 1990-05-08 | Concept, Inc. | Surgical cutting instrument with titanium nitride coating on an inner tubular member |
US5255669A (en) * | 1989-04-12 | 1993-10-26 | Olympus Optical Co., Ltd. | Ultrasonic treatment apparatus |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
US5151085A (en) * | 1989-04-28 | 1992-09-29 | Olympus Optical Co., Ltd. | Apparatus for generating ultrasonic oscillation |
US5022399A (en) * | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
US4896811A (en) * | 1989-05-16 | 1990-01-30 | Unisys Corporation | Machine for bonding leads to non-coplanar substrates |
US5029588A (en) * | 1989-06-15 | 1991-07-09 | Cardiovascular Imaging Systems, Inc. | Laser catheter with imaging capability |
US4998527A (en) * | 1989-07-27 | 1991-03-12 | Percutaneous Technologies Inc. | Endoscopic abdominal, urological, and gynecological tissue removing device |
US5076276A (en) * | 1989-11-01 | 1991-12-31 | Olympus Optical Co., Ltd. | Ultrasound type treatment apparatus |
SU1709999A1 (en) * | 1989-12-06 | 1992-02-07 | Ленинградский Научно-Исследовательский Институт Уха, Горла, Носа И Речи | Method for determining effectiveness of the medical treatment of the neuro-sensory hearing loss |
US5069664A (en) * | 1990-01-25 | 1991-12-03 | Inter Therapy, Inc. | Intravascular ultrasonic angioplasty probe |
US5211625A (en) * | 1990-03-20 | 1993-05-18 | Olympus Optical Co., Ltd. | Ultrasonic treatment apparatus |
US5100423A (en) * | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
US5269291A (en) * | 1990-12-10 | 1993-12-14 | Coraje, Inc. | Miniature ultrasonic transducer for plaque ablation |
US5248296A (en) * | 1990-12-24 | 1993-09-28 | Sonic Needle Corporation | Ultrasonic device having wire sheath |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5312328A (en) * | 1991-01-11 | 1994-05-17 | Baxter International Inc. | Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels |
US5267954A (en) * | 1991-01-11 | 1993-12-07 | Baxter International Inc. | Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels |
US5261877A (en) * | 1991-07-22 | 1993-11-16 | Dow Corning Wright | Method of performing a thrombectomy procedure |
US5242385A (en) * | 1991-10-08 | 1993-09-07 | Surgical Design Corporation | Ultrasonic handpiece |
US5188589A (en) * | 1991-10-10 | 1993-02-23 | Alcon Surgical, Inc. | Textured irrigating sleeve |
CA2122834C (en) * | 1991-11-04 | 1999-10-05 | Henry Nita | Ultrasonic ablation device adapted for guidewire passage |
US5199943A (en) * | 1991-12-12 | 1993-04-06 | Alcon Surgical, Inc. | Ultrasonic surgical handpiece |
US5269297A (en) * | 1992-02-27 | 1993-12-14 | Angiosonics Inc. | Ultrasonic transmission apparatus |
-
1993
- 1993-10-04 US US08/131,796 patent/US5447509A/en not_active Expired - Lifetime
-
1994
- 1994-09-30 AT AT94929948T patent/ATE236579T1/en not_active IP Right Cessation
- 1994-09-30 WO PCT/US1994/011060 patent/WO1995009572A1/en active IP Right Grant
- 1994-09-30 DE DE69432469T patent/DE69432469T2/en not_active Expired - Fee Related
- 1994-09-30 JP JP7510904A patent/JP2811123B2/en not_active Expired - Lifetime
- 1994-09-30 CA CA002173446A patent/CA2173446C/en not_active Expired - Fee Related
- 1994-09-30 EP EP94929948A patent/EP0722295B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1995009572A1 (en) | 1995-04-13 |
CA2173446A1 (en) | 1995-04-13 |
ATE236579T1 (en) | 2003-04-15 |
JP2811123B2 (en) | 1998-10-15 |
DE69432469T2 (en) | 2004-02-26 |
EP0722295A1 (en) | 1996-07-24 |
US5447509A (en) | 1995-09-05 |
JPH09503146A (en) | 1997-03-31 |
EP0722295B1 (en) | 2003-04-09 |
DE69432469D1 (en) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2173446C (en) | Ultrasound catheter system having modulated output with feedback control | |
US4827911A (en) | Method and apparatus for ultrasonic surgical fragmentation and removal of tissue | |
US10052120B2 (en) | Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue | |
US5474530A (en) | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasospasm | |
CN113993463A (en) | Ultrasound systems and methods with improved occlusion engagement during cross and atherectomy procedures | |
CN103237516B (en) | For the system and method that adaptability RF melts | |
US5968007A (en) | Power-limit control for ultrasonic surgical instrument | |
US5158560A (en) | Laser operating device for intracavitary surgery | |
CN111214288A (en) | Radio frequency ablation power output control method and device and radio frequency ablation system | |
EP3895632A1 (en) | Ultrasound catheter system | |
US20070225615A1 (en) | Guidewire controller system | |
JPH09299381A (en) | Ultrasonic operation device | |
CA1327062C (en) | Laser operating device for intracavitary surgery | |
WO2022182640A1 (en) | Therapeutic ultrasonic interventional system | |
WO2022182648A1 (en) | Method for controlling a therapeutic ultrasonic interventional system | |
CN117562621A (en) | Shock wave energy control system | |
AU2013270487B2 (en) | Vacuum sense control for phaco pulse shaping | |
CN116531053A (en) | Ultrasonic lithotripsy method and system for intelligently identifying urinary calculi | |
EP0377051A1 (en) | Laser-aided intravascular operation equipment | |
JPS5886154A (en) | Electric knife apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |